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ABSTRACT OF THE DISSERTATION 
DEVELOPMENT OF ADVANCED CAPILLARY ELECTROPHORESIS 
TECHNIQUES WITH UV AND MASS SPECTROMETRY DETECTION FOR 
FORENSIC, PHARMACEUTICAL AND ENVIRONMENTAL APPLICATIONS 
by 
Hanzhuo Fu 
Florida International University, 2014 
Miami, Florida 
Professor Bruce R. McCord, Major Professor 
Capillary electrophoresis (CE) is a modern analytical technique, which is 
electrokinetic separation generated by high voltage and taken place inside the small 
capillaries. In this dissertation, several advanced capillary electrophoresis methods are 
presented using different approaches of CE and UV and mass spectrometry are utilized as 
the detection methods.  
Capillary electrochromatography (CEC), as one of the CE modes, is a recent 
developed technique which is a hybrid of capillary electrophoresis and high performance 
liquid chromatography (HPLC). Capillary electrochromatography exhibits advantages of 
both techniques. In Chapter 2, monolithic capillary column are fabricated using in situ 
photoinitiation polymerization method. The column was then applied for the separation 
of six antidepressant compounds.  
Meanwhile, a simple chiral separation method is developed and presented in 
Chapter 3. Beta cycodextrin was utilized to achieve the goal of chiral separation. Not 
only twelve cathinone analytes were separated, but also isomers of several analytes were 
vii 
 
enantiomerically separated. To better understand the molecular information on the 
analytes, the TOF-MS system was coupled with the CE. A sheath liquid and a partial 
filling technique (PFT) were employed to reduce the contamination of MS ionization 
source. Accurate molecular information was obtained. 
It is necessary to propose, develop, and optimize new techniques that are suitable 
for trace-level analysis of samples in forensic, pharmaceutical, and environmental 
applications. Capillary electrophoresis (CE) was selected for this task, as it requires lower 
amounts of samples, it simplifies sample preparation, and it has the flexibility to perform 
separations of neutral and charged molecules as well as enantiomers. 
Overall, the present work demonstrates the versatility of capillary electrophoresis 
methods in forensic, pharmaceutical, and environmental applications. 
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CHAPTER 1 GENERAL INTRODUCTION 
"The journey of a thousand miles begins with a single step." 
Lao Tzu, Chinese philosopher, 604 BC–531 BC. 
1.1 Historical Background 
The history of capillary electrophoresis can be traced back to the 19th century, 
when Lodge described “hydrogen ion movements in a tube of phenolphthalein jelly” [1, 2] 
in his thesis in 1886. Later, Smirnow [3], Hardy [4, 5], and Field [6] continued the 
development of electrophoresis systems. During this time, separations were performed in 
U shaped glass tubes with electrodes attached to each of the tubes’ arms [4, 5]. In 1937, 
Swedish scientist Tiselius [7] successfully applied electrophoretic techniques for the 
separation of colloidal mixtures. As a result of his pioneering work, Tiselius was awarded 
the Nobel Prize in Chemistry in 1948, "for his research on electrophoresis and adsorption 
analysis, especially for his discoveries concerning the complex nature of the serum 
proteins" [8]. Professor Tiselius continued his explorations in the field of electrophoresis 
and a number of more inspiring results were published, including separation of virus 
particles in a 3 mm I.D. capillary [9-13]. In 1967, Hjerten [14] demonstrated the 
separation of proteins using a 3 mm I.D. capillary, which was the earliest example of the 
use of capillaries for electrophoretic separations with high electric fields. Afterwards in 
1974, Virtenen discussed several advantages of using smaller diameter columns in 
electrophoretic separations. However, the studies conducted in earlier years were not able 
2 
 
to demonstrate the high efficiencies which the modern CE systems have because of their 
inability to produce stable capillary columns. 
The commonly accepted modern CE system was introduced by James W. 
Jorgenson, who was a professor at University of North Carolina, Chapel Hill, with his 
graduate student Krynn Lukacs. Because of their pioneering work in the 1980s [15-18], 
the CE system was widely used in academia, and resulted in CE industrial commercial 
availability in the late 1980s. For example, in their paper titled capillary zone 
electrophoresis published in Science magazine in 1983 [16], fundamental concepts of 
modern capillary electrophoresis such as zone broadening as well as theoretical ideas on 
CE separation mechanisms were proposed and presented. In the paper, they applied 
voltages as high as 30 kV and adapted online UV detection for the separation of ionic 
species.  
Meanwhile, micellar electrokinetic chromatography (MEKC), another milestone 
of CE development, was introduced by Professor Terabe in 1984 [19]. This invention 
presented a method for using electrophoresis to separate both charged and neutral species 
and was another vital step in CE history. After that, several types of CE separation modes 
were invented and introduced [20-24]. 
Today, capillary electrophoresis is gaining great popularity as a powerful 
analytical tool for various applications. Figure 1.1 illustrates the number of scientific 
articles published over past three decades on the topic of “Capillary Electrophoresis” 
using capillary electrophoresis as the key word in conducting a search using the Scifinder 
Database. 
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Figure 1.1 Literature published between 1983 and 2013 on the topic of Capillary 
Electrophoresis using capillary electrophoresis as the key work to conduct the search. 
Data source: Scifinder database. 
1.2 Principles of Separation in Capillary Electrophoresis 
Capillary electrophoresis is a useful technique for the analysis of a wide variety of 
compounds, including chiral compounds, pharmaceutical molecules, peptides, and 
proteins [2, 25]. In particular, capillary electrophoresis has been successfully applied to 
the determination of drugs in toxicological samples [26]. The usage of CE in forensic 
analysis mainly results from advantages such as minimal sample requirements, rapid 
analyses, and high efficiencies. 
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Capillary electrophoresis separation is determined by two factors: electroosmotic 
flow (EOF) and electrophoretic mobility [2]. Electrophoretic mobility is the motion of 
liquid induced by an applied potential across a capillary column. Electroosmotic flow 
originates from the negative charges on the inner wall of the capillary tube, which result 
in the formation of an electrical double layer. This is known as the zeta potential, which 
is expressed by ς, and defined by the Helmholtz equation [27]. 
 
Figure 1.2 Schematic diagram of the capillary electrophoresis system. The high voltage 
up to 30 kV is applied at the ends of the capillary. With the force combination of 
electrophoretic mobility and electroosmotic flow, the samples and background 
electrolytes are carried through the capillary from the inlet to the outlet. A short portion 
of the capillary is created as the detection window in order to obtain electrophoretic 
spectra from UV or fluorescence detectors. 
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Equation 1.1 Helmholtz equation 

  eo4  
where η is the viscosity, ε is the dielectric constant of the buffer, and μeo is the coefficient 
for electroosmotic flow. Equation 1.1 can be used to categorize the effects of various 
parameters on the EOF as under the influence of an applied electric field, the cations in 
the diffuse layer move towards the cathode, leading the solvent molecules to move in the 
same direction. 
The linear velocity, expressed by ν, of the electroosmotic flow is defined by the 
following equation. 
Equation 1.2 Calculation of linear velocity ν 
ߥ ൌ ε4ߨߟ 	E	ζ 
And the number of the theoretical plates is expressed as Equation 1.3, where E is the 
potential of the electric field. 
Equation 1.3 Calculation of theoretical plates (N) 
 ܰ ൌ ሺఓ௘௢ାఓ௘௣ሻ௏ଶ஽  
Where μep is the electrophoretic mobility and D is the diffusion coefficient of the solute. 
Separations in CE occurs based on differences among electrophoretic mobilities of 
solvated ions as shown in Figure 1. High efficiencies occur in these separations because 
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the system flow is electro-driven rather than pressure-driven as in an HPLC system. 
Diffusion is minimized in the small 50 µm flow channel. 
Figure 1.3 illustrates the separation mechanism of capillary electrophoresis and 
electroosmotic flow forms in a capillary. The wall of the capillary attracts cations in the 
electrolyte, and an electrical double layer is created. Once voltage is applied to the 
capillary, the net motion of electrolytes towards the cathode (EOF) occurs.  
 
Figure 1.3 Formation of the electroosmotic flow from the double layer inside the 
capillary. Adapted from Ref. [28]. 
Equation 1.4 Separation mechanism of the capillary electrophoresis system 
 
          As stated above, the two different forces, electroosmotic fow µeo, and 
electrophoretic mobility µep, play roles in the separation of the capillary electrophoresis 
epeo  
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system. pH values have an important impact on the flow directions of the two forces, 
which is demonstrated as Figure 1.4. 
 
Figure 1.4 Mechanism of separations in capillary electrophoresis systems. The 
combination of electrophoretic mobility µep and electroosmotic flow µeo determines the 
flow velocity of the eluents in the capillary. Generally, at high pH conditions, silanol 
groups on the inside wall of the capillary are fully ionized, generating a strong zeta 
potential and dense electrical double layer. The overall separation is based on the two 
forces. 
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In Figure 1.5, flow profiles in CE and HPLC are presented. As a result of its 
contribution to peak broadening, the pressure driven flow profile inherently limits the 
efficiency of HPLC. In CE, the EOF results in a flat flow profile towards the counter 
electrode with charged compounds migrating at various rates within this vector.  
 
Figure 1.5 A comparison between electroosmotic flow and laminar flow. Laminar flow 
results in increased diffusion and band broadening and is a characteristic of HPLC 
separations while the flat flow profile of the EOF improves separation efficiency in CE. 
Adapted from Ref. [2]. 
9 
 
            Figure 1.6 displays CE sample stacking and sample injection. Samples are first 
injected by either electrokinetic mode (voltage) or pressure. Then high voltage up to 30 
kV is applied towards the samples. Samples are moved to the outlet based on different 
forces. 
 
Figure 1.6 CE sample stacking and sample injection. Top: the analyte is injected. Middle: 
high voltage filed (up to 30 kV) is applied and since the electric potential difference 
exists, the samples are pushed towards the cathode end. Bottom: the sample ions are 
stacked and migrating though the capillary as a zone that is narrower than the sample 
injected. Adapted from Ref. [2] and [29]. 
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1.3 Significance of the Work 
In this dissertation, different capillary electrophoresis methods are utilized to 
examine effects in the separation and detection of drugs and toxins in forensic, 
pharmaceutical, and environmental applications. 
The detection of compounds involved in illicit and prescription drug abuse 
The use of illicit drugs and the concomitant large number of problematic drug 
users is a serious problem in work health [30]. According to the World Drug Report 2013 
released by the United Nations Office on Drugs and Crime (UNODC), “ between 167 and 
315 million people between the age of 15–64 were estimated to have used an illicit 
substance” [30] in the year of 2010. This corresponds to between 3.6% and 6.9% of the 
adult population in the world [30]. Figure 1.7 demonstrates that since 2008 the estimated 
total number of people who have used an illicit drug has increased by 18%. This issue 
makes it vital for law enforcement officers, policy makers, and researchers to find 
corresponding solutions to fight against synthetic and designer drugs of abuse. 
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Figure 1.7 Trends in drug use from 2006 to 2011. Date source: the World Drug Report 
2013, UNODC. [30] 
Environmental issues 
The Annual Report 2013 from the United Nations Environment Programme 
(UNEP) [31], and the Annual Report 2012 from Greenpeace [32], summarized various 
issues in the 21st century that human beings are facing, such as global warming and 
greenhouse effect, CO2 emission, food safety and food security, air pollution, and 
drinking water shortage. Among them, drinking water safety is one of the most important 
aspect for human safety. A threat to clean drinking water includes cyanobacteria, which 
are widely distributed throughout the world, which reflects their genotypic and 
phenotypic variation [33]. Cyanobacteria are common in diverse types of every terrestrial 
habitat, including oceans, lakes, fresh water, deserts, and even in the extreme 
environments of Antarctica and thermal springs [34-35]. Thus, it is important to not only 
detect but also quantify the amount of cyanobacteria existing in drinking water 
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CE to the rescue 
Numerous scientific publications have reported various analytical methods for 
analysis of synthetic and designer drugs of abuse, overdosed prescriptions, and 
environmental toxins such as cyanobacteria. Some application examples include HPLC 
and LC-MS (including LC-MS/MS) [34-41], GC and GC-MS [42-47], and other 
techniques [48-54] such as SFC, TPLC, and ELISA. However, capillary electrophoresis 
has some advantages over these approaches mentioned above, which has made CE a 
powerful tool for fulfilling the goal of projects in this dissertation. To summarize, 
capillary electrophoresis i) requires less sample injection amount; ii) has high efficiency, 
high selectivity, and low operation cost; iii) exhibits the ability to analyze non-volatile 
and highly polar compounds, and iv) demonstrates relatively easy column modification to 
achieve chiral separation ability. 
This dissertation is focused on development of novel CE techniques for forensic, 
pharmaceutical, and environmental applications. A number of approaches were examined 
for different applications and are presented in each following chapters. 
 
 
 
 
 
 
13 
 
CHAPTER 2 MONOLITHIC CAPILLARY ELECTROCHROMATOGRAPHY FOR 
THE TRICYCLIC ANTIDEPRESSANTS 
 
2.1 Introduction 
2.1.1 Introduction of the project  
Worldwide issues with poisoning and death from clandestine drug manufacturing 
demonstrate the need for effective methods that can not only detect low levels of drugs 
but also accurately confirm their molecular information. In this way law enforcement can 
better track users and victims of these products. In addition, the field of toxicology has 
become increasingly vital as researchers and practitioners recognize the importance of 
defining the precise role different drug combinations play in human behavior [33]. As a 
result, a large number of studies have been conducted to develop better ways to detect the 
presence of dangerous drugs [34-37]. The goal of the research described in this chapter is 
to develop novel methods for the detection of drugs using capillary 
electrochromatography (CEC). 
Trace detection of pharmaceutical compounds typically employs several 
analytical techniques, including gas chromatography-mass spectrometry (GC-MS) and 
liquid chromatography-mass spectrometry (LC-MS). For the separation of drugs with 
very similar structural and physical properties, these techniques may require specialized 
stationary phases or additional derivatization for some samples in order to increase 
method selectivity. An alternative to above techinuqes is to utilize capillary 
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electrophoresis (CE).  Because of its high resolution and excellent peak capacity, 
capillary electrophoresis can be a powerful alternative to traditional separation methods 
for ionic analytes as well as neutral drugs. To permit the separation of neutral drugs, 
compounds may be added to the buffer to produce guest/host and micellar/solute 
interactions with the analytes. Using compounds such as cyclodextrins in the buffer, even 
chiral compounds can be separated [2]. However, while capillary electrophoresis coupled 
with UV, electrochemical or fluorescence detection can be used to presumptively 
determine the presence of a particular compound, mass spectrometry connected to 
chromatography is necessary for absolute identity of any drugs present in sample matrix  
[55]. For toxicological analysis a number of useful procedures have been developed for 
the detection and screening of compounds by capillary electrophoresis-mass spectrometry 
(CE-MS) including low sample consumption and the potential for highly efficient chiral 
analysis. However, current applications involving neutral or chiral drug detection by CE 
procedures have been problematic [2, 25]. Since these procedures perform separations 
utilizing non-volatile detergents or cyclodextrin-based pseudo-stationary phases, these 
methods generally are incompatible with electrospray ionization methods that require 
volatility. One potential solution for this issue is to operate the CE-MS system in a partial 
filling mode to avoid spraying the reagent into the mass spectrometer. However, the 
partial filling method is not often viable because of problems controlling the timing of the 
capillary fill step and the potential instability of buffer gradient step that results from the 
process. 
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Capillary electrochromatography (CEC) is an alternative method for 
electrophoretic separation that can be employed in the application of drug analysis. This 
procedure is a novel technique which permits the detection of neutral compounds by 
combining the high efficiency of CE with the outstanding selectivity of HPLC. In CEC, 
the capillary column is packed with an HPLC type stationary phase, which allows the 
separation to occur via sample partitioning between the packed stationary phase and an 
electrodriven mobile phase. An efficient way to produce the stationary phase is through 
in-situ polymerization into a so called polymer monolith. When coupled with mass 
spectrometry, the procedure has been shown to provide efficient and sensitive detection 
of drugs and their metabolites in biological fluids. 
2.1.2 Background and significance of capillary electrophoresis and capillary 
electrochromatography 
Capillary electrochromatography was first introduced by Pretorius [56] and a 
wide variety of applications have been developed for the technique [57]. In CEC a high 
voltage is applied across the capillary, to generate EOF and move the mobile phase along 
with analytes through the column. Separations for CEC are a consequence of both 
differential partitioning and electrophoretic migration in mobile phases, which typically 
include a mixed aqueous/organic buffer [58]. Since CEC is a hybrid of CE and HPLC, 
high pressure is introduced to the system in order to assist with the electrophoretic 
mobility as well as reducing the formation of bubbles when preparing monolithic 
capillary columns. 
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Figure 2.1 Schematic diagram of the CEC system. 1, inlet buffer vials; 2, 
capillary; 3, outlet buffer vials; 4, electrodes; 5, power supply; 6, point of detection; 7, 
external pressure 2-12 bar. The power supply (5) provides voltages up to 30 kV to the 
two buffer vials at the distal ends of capillary (1, 3). The applied voltage creates an 
electroosmotic flow (EOF) within the capillary (3) moving the analytes down the column 
where they interact with the stationary phase. A detection window (6) is placed near the 
end of the capillary which is typically UV, fluorescence, or mass spectrometry. Adapted 
from Ref. [2]. 
In CEC, the stationary phase has two major roles: to provide charged sites to 
permit the desired EOF for mass transport across the column, and to offer interactive sites 
for chromatographic retention. A convenient way to generate a CEC stationary phase 
with proper anionic character for generating EOF involves the production of monolithic 
stationary phases. A monolithic column is defined as “A continuous unitary porous 
structure prepared by in situ polymerization or consolidation inside the column tubing 
and, if necessary, the surface is functionalized to convert it into a sorbent with the desired 
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chromatographic binding properties” [59]. Two approaches can be used for making 
monolithic stationary phases: sol-gels and organic polymers. The polymeric method is 
often used because of its simplicity. In addition, the polymeric method is easy to 
chemically modify to induce selectivity changes [25, 60]. The procedure consists of four 
main steps: first using a promoter solution for pretreatment of the capillary walls to 
increase sorption sites; the polymerization mixture is then used for flushing the capillary. 
Under UV radiation exposure or heat, the mixture is initiated by in situ polymerization. 
Lastly, unreacted components are removed and a detector window is created by exposing 
a section to UV light [27, 58]. The polymerization mixture is made of monomers, a 
chemical initiator, and the porogen. The charged monomers assist in generating 
electroosmotic flow, while the retentive monomers establish partitioning sites. Separation 
selectivity can be enhanced by altering the hydrophobicity of the capillary’s stationary 
phase [60]. The monolithic polymerization process may include altering the functional 
groups on the monomer or altering the carbon chain length [61]. Formation of the 
polymer chains is enhanced by the cross-linker, and the free radical polymerization 
process is started by the initiator, resulting in the formation of the monolithic column. 
The porogens play an important role as well because they assist in the formation of a 
large network of pores in the polymeric monolith through which the mobile phase can 
traverse [60]. 
Blas et al. [58] described the separation and detection of benzodiazepines in urine 
samples using monolithic CEC-TOF-MS. Enhanced sensitivity was achieved because of 
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two factors: the usage of the TOF-MS system and preconcentration at the tip of the 
capillary containing the monolithic materials. 
 
Figure 2.2 Comparison of electrophoresis, electrochromatography and chromatography. 
Different flow profiles are exhibited for electrophoresis, electrochromatography, and 
chromatography. Adapted from Ref. [62]. 
Separation selectivity can be enhanced by altering the monomers and side groups 
[62-63]. For example, hydrophobicity can be altered through increases in the length of 
the carbon side group from hexyl to octadecyl acrylate. Charge density and pore size can 
also affect separation through changes in sulfonate concentration and through increased 
addition of cross linkers [57-59]. 
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Antidepressants (ATD), as the names indicate, are substances with a wide range 
of therapeutic uses for treatment of depressive disorder, and other conditions such as 
anxiety and dysmenorrhoea. The World Health Organization (WHO) reported that 
depression is the world’s third-leading cause of death loss [63]. Because of their side 
effects and possible harmful potential, strict limitation is placed on the usage of 
antidepressants. Among the wide variety  of antidepressants, the most significant classes 
are the selective serotonin reuptake inhibitors (SSRIs), serotonin–norepinephrine 
reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and monoamine oxidase 
inhibitors (MAOIs) [64, 65]. In this project, I focused mainly on TCAs(Figure 2.3). 
 
Figure 2.3 Structures of analytes used in Chapter 2 
A number of different analytical techniques have been used in the trace detection 
of antidepressant compounds. Gas chromatography (GC) and gas chromatography – mass 
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spectrometry (GC-MS) [66-69] have been used to analyze ATD compounds. However, 
chemical derivatization is required to increase volatility of many analytes to permit 
compatibility with GC methods. High performance liquid chromatography (HPLC) and 
liquid chromatography – mass spectrometry (LC-MS) [70-74] have often been used as an 
alternative to GC and GC-MS for these compounds. However, most published work was 
focusing on screen and determination rather than separation [73-75]. A useful alternative 
is capillary electrophoresis. A number of capillary electrophoresis (CE) and CE combined 
with MS methods have also been explored [26, 75-77]. 
Capillary electrochromatography (CEC) as an alternative method can be 
employed in the application of drug analysis. Electrochromatography was first introduced 
by Pretorius [56]. In CEC a high voltage is applied across the capillary, to generate EOF 
and move the mobile phase through the column. Several applications of CEC monolith 
capillary columns have been reported and reviewed [61, 78-83]. However, to the author’s 
knowledge, there are no published reports on the use of acrylate-based monolithic CEC 
for ATDs detection. 
2.2 Experimental 
2.2.1 Chemicals and materials 
Fused-silica capillaries with an inner diameter of 100 µm and a UV-transparent 
coating were purchased from Polymicro Technologies (Phoenix, AZ, USA). Hexyl 
acrylate (HA), 2-acrylamido-2-methyl-1-propanesulfonic acid (AMPS), 2,2’-
azobisisobutyronitrile (AIBN), and sodium phosphate dibasic heptahydrate were obtained 
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from Acros Organics (Morris Plains, NJ, USA). One, three-butanediol diacrylate 
(BDDA), trimethyoxysilylpropyl acrylate (TMSA), ammonium acetate, ammonium 
dihydrogen phosphate, ammonium formate, and sodium phosphate monobasic 
monohydrate were obtained from Sigma Aldrich (St. Louis, MO, USA). Acetone, 
acetonitrile, and ethanol from were purchased from Fisher Scientific (Pittsburgh, PA, 
USA). Distilled water was deionized by a Milli-Q water purification system (Millipore, 
Bedford, MA, USA). Antidepressants standards were purchased from Sigma Aldrich (St. 
Louis, MO, USA). 
Table 2.1 Chemical components of monolithic mixture 
Chemical Name Chemical Structure Function 
Hexyl Acrylate (HA)  Monomer 
1,3-butanediol diacrylate 
(BDDA) 
 Cross-linker 
trimethoxysilylpropyl 
acrylate 
 Adhesion Promoter 
2-acrylamido-2-methyl-1-
propanesulfonicacid 
(AMPS) 
 Support Electroosmotic 
Flow 
2,2'-azobisisobutyronitrile 
(AIBN) 
 
Free Radical Initiator for 
Polymerization 
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2.2.2 Instrumentation 
All experiments were carried out using a fully automated capillary electrophoresis 
system (G1600, Agilent Technologies, CA, USA) with the column temperature 
maintained at 25°C. Separations were performed in 100 µm ID uncoated fused silica 
capillaries with a total length of 60 cm and an effective length of 50 cm. The running 
voltage was 30 kV and samples were injected using the electrokinetic injection mode for 
5 s at 10 kV. A built-in diode-array detector (DAD) was employed to record UV 
spectrum. All analytes were scanned from 190 nm to 450 nm, and 206 nm was selected to 
enable maximum sensitivity for analytes [53]. The separations were performed at field 
strengths of 150-950 V/cm. 
For spiked urine sample analysis, an Agilent 3250a time-of-flight mass 
spectrometer (TOF-MS) was employed in addition to the CE system. An orthogonal 
electrospray ionization (ESI) interface was used to couple CE with TOF-MS. Reference 
masses obtained from Agilent (G1969-85001 API-TOF reference mass solution kit) 
including purine at 121.0509 m/z and HP0921 at 922.0098 m/z were added to the sheath 
flow liquid to calibrate the mass spectrometer. The mass range was set to 100-1000 m/z 
to include both reference masses. Applied Biosystems/MSD-SCIEX Analyst QS 
Software (Frankfurt, Germany) was employed for data analysis. All experiments were 
performed in positive ion mode. The TOF-MS conditions were shown in Table 2.2. 
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Table 2.2 ESI-TOF-MS experiment conditions for analysis of spiked urine samples 
Parameter Value 
Capillary Voltage 3000 V 
Nebulizer pressure 10 psi 
Drying gas (N2) 5 L/min 
Gas temperature 150 °C 
Fragmentor voltage 125 V 
Skimmer voltage 40 V 
Octapole RF 300 V 
TOF/PMT 1025 V 
Mass range (m/z) 0-1000 
Sheath flow 0.5 mL/min 
Reference 121.0509, 922.0098 
 
2.2.3 Monolithic capillary preparation 
A method of making monolithic CEC columns was originally developed by Ngola 
et al. [84] and modified to prepare monolith columns. The procedure consists of four 
main steps: first using a promoter solution for pretreatment of the capillary walls in order 
to increase sorption sites; the polymerization mixture is then used for flushing the 
capillary [58]. Under UV radiation exposure or heat, the mixture is initiated by in situ 
polymerization.  Lastly, unreacted components are removed and a detector window is 
created by exposing a section to UV light [27, 58].  
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The polymerization mixture is made of monomers, a chemical initiator, and the 
porogen. The charged monomers assist in generating electroosmotic flow, while the 
retentive monomers establish partitioning sites. Briefly, the monolithic mixtures 
consisting of 1357 µL HA, 591 µL BDDA, 0.0145 g AMPS, 0.0098 g AIBN and 4 µL 
TMSA were prepared. A pH 6.8 sodium phosphate buffer was made from a solution 
containing 3 mM sodium phosphate monobasic and 4 mM sodium phosphate dibasic with 
1.0 M NaOH adjusting to desired pH value. The porogenic mixture was composed of 
acetonitrile, ethanol, and sodium phosphate buffer at 3:1:1 volumetric ratio. The 
monomer mixture was mixed with the porogen at a 1:2 volumetric ratio. Five min of 
sonication was needed to remove bubbles in the mixture. 
Pretreatment towards the capillary was made prior to use, which includes flushing 
the capillary with acetone for 5 min followed by 1.0 M sodium hydroxide for 60 min and 
then treating the inner wall with 4 µL of trimethoxysilylpropyl acrylate in 1 mL 6 mM 
acetic acid for 10 min. The capillary has to be flushed with water for 30 min to remove 
any residual solvent residuals and dried with a flow of nitrogen gas. 
The capillary was filled with the polymerization mixture by immersing the inlet of 
the capillary into a reservoir and pushing the polymerization solution through the 
capillary under gas pressure. After 30 min, both ends of the capillary were sealed. A UV 
detection window was created by masking a 1 cm portion of capillary by aluminum foil. 
The capillary was then placed into an UV box at 365 nm for the duration of 1 h at room 
temperature. Then 2 cm of both ends were cut and the capillary was put in the CE 
instrument for experiments. The monolith must be present in the entire capillary. 
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2.2.4 Sample preparation 
Antidepressant samples were prepared as following procedures. Stock solutions 
were prepared in methanol at a concentration of 1 mg/mL. When not in use, the stock 
solution was stored in the freezer at – 18 °C. For experimental usage, the stock solutions 
were pipetted, dried down under nitrogen, and diluted to concentrations ranging from 5 
ng/mL to 1 mg/mL using deionized water with 10% buffer. Fresh samples were prepared 
daily. 
To check method capability, urine was spiked with cyclobenzaprine, desipramine 
and imipramine at concentrations ranging from 25 ng/mL to 1mg/mL (IRB Protocol 
Approval #: IRB-13-0474) to mimic forensic samples. 
 
Figure 2.4 Monolithic column preparation procedure. The monolithic materials are 
synthesized by monomer mixtures, a chemical initiator, and porogenic solvents. 
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2.2.5 Liquid-liquid extraction 
A liquid-liquid extraction procedure was employed [58] and adjusted as follows: 
1000 µL of spiked urine was mixed with 200 µL of 100 mM ammonium acetate at pH of 
12 and then extracted with 500 µL ethyl acetate. One hundred mL of 0.1 M NaOH was 
then added to the aqueous phase and extracted again with 500 µL ethyl acetate. The 
organic phases were dried down and reconstituted in deionized water with 10% 
phosphate buffer. 
2.3 Results and Discussion 
2.3.1 Monolithic columns 
            Several chemical reactions are involved in the monolithic polymerization 
procedure. The first step is the decomposition of 2,2'-azobisisobutyronitrile (AIBN). 
 
Equation 2.1 Decomposition of 2,2'-azobisisobutyronitrile (AIBN) 
            A 2,2'-azobisisobutyronitrile molecule has one nitrogen-nitrogen double bond and 
two carbon-nitrogen triple bonds. Because N=N has lower bond energy than C≡N, the 
AIBN molecule will take apart into two equal products and the N=N double bond is 
where the free radical reaction takes place. The product will be a t-butyl carbon group 
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with free radicals attached on, which provides reactions sites for the next polymerization 
steps. 
            The second step of the polymerization procedure is the monomer initiation. The 
monomer, hexyl acrylate, reacts with free radicals produced in the first step. The free 
radical attacks the carbon carbon double bond C=C in the hexyl acrylate molecule and 
produces a hexyl carbon chain free radical. 
 
Equation 2.2 Monomer hexyl acrylate (HA) initiation 
            Next, the produced hexyl carbon chain free radical continues reacting with hexyl 
acrylate molecules, producing complex hexyl carbon chain free radicals. 
 
Equation 2.3 Monomer propagation 
            The polymerization reaction continues till it is terminated when the UV initiation 
source is removed. In the case of the reaction used in this project, the UV exposure time 
is set to 60 min. 
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Equation 2.4 Termination of the polymerization reaction 
2.3.2 Method development and CEC-UV results 
The first step of the method development was to fabricate monolithic capillary 
columns, which provided advanced separation performance. Two methods exist for the 
characterization of the quality of a monolithic column. First, UV/Vis spectra of samples 
in the column can be obtained. Second, SEM can be utilized to image the monolithic 
materials inside the column. The figure below illustrates a comparison of effective and 
non-effective monolithic capillary columns. 
Once monolithic columns were successfully fabricated, their performance was 
optimized and characterized. Firstly, the effect of pH was examined.  The optimal 
wavelength was set at the 206 nm as the UV detection wavelength by examining the scan 
of 190 nm to 450 nm to maximize sensitivity. 
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Figure 2.5 Comparison of effective (left side) and non-effective (right side) monolithic 
capillary columns. 
Preliminary results indicated that phosphate buffer was the optimum buffer for 
separation [85, 86]. To begin with, running buffers at different pH’s was investigated.  
pH’s at 2.52, 3.60, 6.13, and 6.95 were examined ( Figure 2.7). From these results it can 
be concluded that at higher pH conditions, antidepressants were better separated. 
To optimize voltage and injection times, a sample containing 200 ng/mL of 
desipramine was injected at different voltages and injection times. A comparison between 
different injection conditions is listed in Table 2.3. 
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Figure 2.6 Scanning electron micrographs of hexyl acrylate monolithic column. Entire 
capillary (top) and enlargement (bottom). Micrographs were taken at 20 kV high electric 
field with x1,000 zoom (top) and x2,000 zoom (bottom), respectively. From the top 
figure, it can be viewed that proper polymerized materials were built inside the column 
and the polymeric materials taken full space inside the column. From the bottom figure, 
porous structure was well developed and the monolithic materials were tightly attached to 
the capillary wall, which indicated that the polymerization process was well finished. 
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Table 2.3 Effect of voltage and duration of injection on peaks. Values are given as 
percentage in relation to the value for 5 kV – 10 s injection. 
 
Various combinations of injection time and voltage were tested, including 5 kV – 
5 s, 5 kV – 10 s, 10 kV – 10 s, and 15 kV – 8 s. Among these parameters, 5 kV – 10 s 
demonstrated optimum results in terms of resolution and peak shape. All other 
combinations of injection are compared with 5 kV – 10s and the results are shown in 
Table 2.3. If longer injection time was used, more samples were injected and sample 
stacking would occur in the capillary; if less injection time adapted, less samples were 
injected and the peak intensity might be lower and not intense enough. For the injection 
voltage, similar principles apply. It can be concluded that 10s is a proper time span to 
ensure enough amount of samples injected into the monolithic columns. Also comparing 
5 kV with 10 kV, 5 kV is relatively proper than the 10 kV. 
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Figure 2.7 CE-UV separations using monolithic capillary columns at different pH 
conditions. Sample: a mixture of 6 antidepressants at 5 µg/mL. BGE: ACN:Phosphate 
Buffer 30:70. Peak identification: Desipramine (1); Cyclobenzaprine (2); Citalopram (3); 
Imipramine (4); Doxepin (5); Fluoxetine (6). Optimum separation conditions and results 
are shown in Figure 2.8. 
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Figure 2.8 Electropherogram of a mixture of six compounds at 50 ng/mL. BGE: 
ACN:Phosphate Buffer 30:70. Run voltage: 30 kV. Injection: 5 s at 10 kV. Cassette 
temperature: 25 °C. Peak identification: Desipramine (1); Cyclobenzaprine (2); 
Citalopram (3); Imipramine (4); Doxepin (5); Fluoxetine (6). 
            Figure 2.8 demonstrates that six antidepressant compounds were separated using 
monolithic capillary columns and analyzed by DAD UV detection. The separation 
conditions are listed in the legend.  
 
 
 
 
 
 
1
2
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            The analytical measurements of the CEC-UV experiments is presented as Table 
2.4. Figures of merit for each analyte including slopes of the calibration curve, coefficient 
of determination (R2), LOD and LOQ are calculated. LOD down to 11 ng/mL was 
obtained. 
Table 2.4 Figures of merit for the CEC-UV results (n≥5) 
 
2.3.3 Liquid-liquid extraction and spiked urine sample 
In order to determine the capability of the procedure for the analysis of biological 
samples, liquid-liquid extraction was explored using spiked urine samples. The urine 
samples were collected using IRB approved protocols from human volunteers (IRB-13-
0474). 
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As stated earlier, 1000 µL of spiked urine was mixed with 200 µL of 100 mM 
ammonium acetate at the pH of 12 and then extracted with 500 µL ethyl acetate. One 
hundred mL of 0.1 M NaOH was then added to the aqueous phase and extracted again 
with 500 µL ethyl acetate. The organic phases were dried down and reconstituted in 
deionized water with 10% phosphate buffer. 
 
 
Figure 2.9 Electropherogram of TOP: Blank urine samples and BOTTOM: spiked urine 
samples of a mixture of three compounds at the concentration of 100 ng/mL. BGE: 
ACN:Phosphate Buffer 30:70. Run voltage: 30 kV. Injection: 5 s at 10 kV. Cassette 
temperature: 25 °C. 
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            A spiked urine sample containing three analytes were examined and the results 
using UV detector are presented as Figure 2.9. A comparison between blank urine and the 
spiked urine samples were. The top figure of Figure 2.9 is shown extraction of blank 
urine sample. No signal was obtained, which matches the character of the blank urine. 
The bottom figure of Figure 2.9 is the spiked urine sample exhibiting three analytes 
cyclobenzaprine, desipramine and imipramine were separated and captured by UV (DAD) 
detector. 
            The spiked urine sample was then infused into the TOF-MS system in order to 
check the extraction capability. The results are presented as Figure 2.10. 
 
Figure 2.10 Mass spectrum of spiked urine sample of a mixture of three compounds at 
the concentration of 100 ng/mL. Three compounds were identified by TOF-MS. M+H 
values as Table 2.5. Detection conditions were same as Figure 2.9. 
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            Exact molecular weight information was obtained for the three antidepressant 
analytes spiked in the sample. Since the TOF is an accurate mass detector, four decimal 
places molecular weight information was given. 
Table 2.5 Accurate mass measurements of extracted urine samples (n≥5) 
 
            Table 2.5 demonstrated the mass measurements of the urine sample extractions. 
Errors in terms of amu and ppm were calculated and presented in the table. Low errors 
(ppm) were obtained, which exhibited the advantages of the TOF-MS system. 
2.4 Concluding Remarks 
This chapter details a method for separation and identification of six 
antidepressant compounds using an acrylate-base porous monolith capillary. Capillary 
electrochromatography (CEC) coupled with UV detector was explored. The CEC-UV 
method provides an effective and efficient method for the separation and identification of 
the analytes. Spiked urine samples were utilized to check method capability. A liquid-
liquid extraction procedure was established to perform sample extraction. Time-of-flight 
mass spectrometry was also employed for spiked urine sample analysis, and accurate 
molecular information was obtained. 
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CHAPTER 3 CHIRAL SEPARATION OF CATHINONE ANALOGS BY 
CYCLODEXTRIN-ASSISTED CAPILLARY ELECTROPHORESIS 
 
3.1 Introduction 
In recent years, there has been a trend towards marketing novel synthetic drug 
analogs as an alternative to conventional controlled substances [87]. Inexpensive organic 
starting materials, inadequate control by law enforcement, and rapid transportation of 
these compounds have lead to the widespread use of such drugs. In addition, the 
increasing use of the Internet makes selling new drugs easier than ever before [88, 89]. 
According to the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA), mephedrone and related substances are primarily sold online and prices 
ranged between 18 and 25 Euros for one gram in 2011 [90]. According to the World 
Drug Report 2013 [30], synthetic cathinones have stimulant effects and are controlled 
substances in most countries. These categories of synthetic drugs are often referred as 
new psychoactive substance (NPS) by UNODC, such as mephedrone and 
methylenedioxypyrovalerone (MDPV). The abuse of synthetic cathinones, also known as 
“bath salts”  (cathinone-type substances such as mephedrone and 
methylenedioxypyrovalerone(MDPV)), has become a major public health threat across 
the world [30]. Case reports and clinical studies have shown that the use of these designer 
drugs can cause severe psychiatric symptoms and possibly death [91-93]. In USA, the 
chemicals used in “bath salts” were under Federal control and regulation announced by 
U.S. DEA in 2011 as “an increasing number of reports from poison control centers, 
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hospitals and law enforcement regarding products containing one or more of these 
chemicals” [94] was received. Strictly control should be implemented and it is necessary 
to analyze and detect cathinone analogs for forensic applications. 
Figure 3.1a Structure of cathinone 
 
 
 
 
Figure 3.1b Structures of all cathinones used in Chapter 3 
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Though the first synthetic cathinones, methcathinone and mephedrone, were 
introduced in the late 1920s, many related compounds have been synthesized [95]. Since 
then, however, most of these have not been used for clinical purposes because of serious 
side effects. Cathinone analogs are amphetamine-like psychostimulants, structurally 
related to the main psychoactive component of the kath plant (Catha edulis), the 
phenylpropylamine alkaloid cathinone (Figure 3.1a) [96]. 
Cathinone analogs are a group of β-keto phenethylamine compounds that are 
derived from the parent compound cathinone shown in Figure 3.1a [97]. Analogs studied 
in Chapter 2 are illustrated in Figure 3.1b. 
Because of existence of a chiral center in cathinone analog compounds, two 
isomers exist for each drug [98]. As with many chiral active pharmaceutical ingredients, 
the pharmacological effect of the enantiomers of those psychoactive compounds can 
differ [99-101]. The enantiomeric separation of cathinone analogs may become important 
as these isomers can perform different functions in drug design and other aspects. 
Many different types of instrumentation and methods have been utilized for the 
separation of cathinone analogs, including HPLC [102-104], GC [99, 105, 106], and CE 
[107-110]. Compared to HPLC and GC, CE demonstrates numerous advantages 
including high efficiency and resolution, and the capability to perform chiral separations 
through the addition of chiral selectors to the background electrolyte (BGE). The chiral 
selector procedure allows easy and fast preparation compared to the required 
modifications of the stationary phase necessary in CEC, HPLC, and GC chiral separation 
[83, 111]. In addition, CE permits low sample injection sizes which are a benefit when 
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sample volumes are limited in most forensic case applications [112]. Capillary 
electrophoresis has been used for cathinone detection, for example, in 2012, Mohr et al. 
[107] described a method of enantioseparation of 19 cathinone derivates with sulfated-β-
CD. However they did not apply mass spectrometric detection to these samples, which is 
a necessary step in forensic case study as a confirmatory method.   
A major advantage of capillary electrophoresis over other separation techniques is 
its capability of separation in the area of chiral analysis [107-110, 113]. Furthermore, the 
technique has wide applications in forensic toxicology, as demonstrated by the numerous 
papers published in the field by Fanali, Lurie, and others [109, 113-116]. In this project 
presented in Chapter 3, the capability of CE has been investigated in the determination of 
synthetic cathinone analogs. With CE, numbers of chiral selectors are available for use, 
including crown ether [117-127] and antibiotics [128-135]. Among them, cyclodextrins 
(CDs) and their analogs are the most commonly used [107, 136]. 
Compared to other chiral selectors, cyclodextrin has its own advantages: i. it is 
relatively cheaper than crown ether [137], which is another widely used chiral selector; ii. 
CD has a low UV signal shield at 200-250 nm, which is especially useful for the target 
compounds used in this project; and iii.it is easy to synthesize CD derivatives on the basis 
of CD’s neutral α-, β- and γ-CD forms since the OH- groups on the edge of CD ring 
provide various anchoring sites. However, cyclodextrin is a non-volatile compound, 
which means once it gets into the MS ionization source, it is difficult to remove. In this 
case, other than spraying buffer containing the CD directly into the MS, a novel approach 
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should be implemented for CE coupling with MS. This part (CE-MS) will be mainly 
discussed in the next chapter (Chapter 4). Chapter3 is focused on CE-UV mode. 
 
 
Figure 3.2 TOP: The structure of β-cyclodextrin from top view and BOTTOM: Side 
view with diameter and height values of β-cyclodextrin molecule. 
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The possible separation mechanism of CD was proposed by Prof. Bezhan 
Chankvetadze of Tbilisi State University [138]. He concluded that “… in order to be 
separated by CE, the enantiomers must migrate with different velocities along the 
longitudinal axis of a separation capillary” [138], and to accomplish such goal, it is 
necessary to add the chiral selector to BGE. The mechanism is expressed as the following 
equation: 
Equation 3.1 Separation mechanism of CD proposed by Chankvetadze [138] 
∆μ ൌ ሺμ୤ 	െ	μୡሻሺKୗ െ KୖሻሾCሿ1 ൅ ሺKୖ ൅ KୗሻሾCሿ ൅	KୖKୗሾCሿଶ 
where ∆μ represents the velocity difference between isomers of the same chiral 
analyte, μf and μc are mobility of the non-complex form and mobility of complex form, 
respectively. The variable [C] represents the concentration of chiral selector, and the 
complexation constants of R and S isomers are expressed as KR and KS. Equation 3.1 
explains that when the two enantiomers react with CD and the diasterometric products 
have their own velocity and enantiomers-chiral selector complexation constants, a 
velocity difference between the two enantiomers exists, so the two enantiomers elute out 
the capillary at different migration times. 
In 1997, another assumption was proposed, that even when KR = KS = K, chiral 
separation can be achieved by CE. In this scenario, Equation 3.1 is transformed to the 
following equation. 
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Equation 3.2 Separation mechanism of CD when association constants are at the same 
value [138]. 
∆μ ൌ ሺμୡୖ 	െ	μୡୗሻKሾCሿ1 ൅ KሾCሿ  
The goal of the particular project presented in Chapter 3 was to develop a method 
for simultaneous chiral analysis of multiple cathinone analogs by cyclodextrin-assisted 
CE. In addition, the author was interested in developing a procedure to permit coupling 
the chiral separations with time of flight mass spectrometry (TOF-MS). In this way one 
could also obtain the exact mass information useful in compound detection and 
identification by the TOF-MS. In Chapter 3, the CE-UV part of the project is mainly 
discussed. Detailed experimental procedures and method development of CE-TOF-MS 
section will be demonstrated in Chapter 4. 
3.2 Experimental 
3.2.1 Chemicals 
Phosphoric acid and acetic acid were purchased from Fisher Scientific (Pittsburgh, 
PA, USA); ammonium acetate, sodium hydroxide, sulfated β-cyclodextrin, highly 
sulfated-β-cyclodextrin, and sodium phosphate monobasic monohydrate from Sigma-
Aldrich (St. Louis, MO, USA); β-cyclodextrin and γ-cyclodextrin from TCI America 
(Portland, OR, USA); and highly sulfated γ-cyclodextrin from Beckman Coulter (Brea, 
CA, USA). Distilled water was produced with a Barnstead Nanopure Diamond water 
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system (Waltham, MA, USA). Sodium phosphate dibasic heptahydrate were obtained 
from Acros Organics (Morris Plains, NJ, USA). 
Acetonitrile (ACN), methanol (MeOH), Isopropanol, and phosphoric acid used 
for the preparation of the buffer electrolytes, were of analytical reagent grade (Carlo Erba, 
Milan, Italy). Distilled water was deionized by a Milli-Q water purification system 
(Millipore, Bedford, MA, USA).  
A number of experiments were performed in the author’s Italian collaborator’s lab. 
For method development in the Italian lab facility (UV/Vis detection), drug standards of 
(±)-2-(methylamino)-1-phenylbutan-1-one hydrochloride (Buphedrone), (±)-1-phenyl-2-
(methylamino)pentan-1-one hydrochloride (Pentedrone), (±)-1-(4-methoxyphenyl)-2-
(methylamino)propan-1-one hydrochloride (Methedrone), (±)-1-(3,4-dimethylphenyl)-2-
(methylamino)propan-1-one  hydrochloride (3,4-DMMC), (±)-2-ethylamino-1-phenyl-
propan-1-one hydrochloride (Ethcathinone), (±)-1-(4-fluorophenyl)-2-
methylaminopropan-1-one hydrochloride (4-Fluoromethcathinone), (±)-2-
dimethylamino-1-phenylpropan-1-one hydrochloride (Dimethylcathinone), (±)-2-
methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one hydrochloride (Methylone), 
(±)-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one hydrochloride (Ethylone), (±)-
2-methylamino-1-(4-methylphenyl)propan-1-one hydrochloride (Mephedrone), (±)-1-
(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one hydrochloride (Pentylone), (±)-1-
(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one hydrochloride (MDPV) and 
(±)-2-(ethylamino)-1-phenyl-1-propanone hydrochloride (Ethcathinone) were purchased 
from LGC Standards (Sesto San Giovanni, Milan, Italy).  
46 
 
For method development in USA lab facility (UV/Vis and CE/MS) at FIU, drug 
standards of (±)-2-(methylamino)-1-phenylbutan-1-one (Buphedrone), (±)-1-phenyl-2-
(methylamino)pentan-1-one (Pentedrone), (±)-1-(4-methoxyphenyl)-2-
(methylamino)propan-1-one (Methedrone), (±)-1-(3,4-dimethylphenyl)-2-
(methylamino)propan-1-one  (3,4-DMMC), (±)-2-ethylamino-1-phenyl-propan-1-one 
(Ethcathinone), (±)-1-(4-fluorophenyl)-2-methylaminopropan-1-one (4-
Fluoromethcathinone), (±)-2-dimethylamino-1-phenylpropan-1-one (Dimethylcathinone), 
(±)-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (Ethylone), (±)-1-(1,3-
benzodioxol-5-yl)-2-(methylamino)pentan-1-one (Pentylone), and (±)-2-(ethylamino)-1-
phenyl-1-propanone, monohydrochloride (Ethcathinone) were purchased from Cayman 
Chemical (Ann Arbor, MI, USA) and drug standards of (±)-2-methylamino-1-(4-
methylphenyl)propan-1-one (Mephedrone), (±)-1-(Benzo[d][1,3]dioxol-5-yl)-2-
(pyrrolidin-1-yl)pentan-1-one (MDPV) and (±)-2-methylamino-1-(3,4-
methylenedioxyphenyl)propan-1-one (Methylone) were purchased from Lipomed 
(Cambridge, MA, USA). The chemical structures of cathinones are represented in Figure 
1b.  
Stock solutions of synthetic cathinones (0.1 mg/mL) were prepared in methanol 
and stored at -20 °C. Background electrolytes (BGE) used for CE experiments were 
prepared daily by dissolving the proper amount of β-cyclodextrins in phosphate buffer. 
All the electrolyte solutions for the CE separation were stored in glass bottles at + 4 °C. 
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Background electrolyte preparation 
Phosphate buffers were prepared by diluting concentrated phosphoric acid to a 
desired concentration, in this project to a 100 mM phosphate buffer and adjusting with a 
1.0 M NaOH solution in order to reach the working pH (= 2.5). In the experiments 
evaluating the influence of the pH on separation performance, 100 mM solutions of 
phosphoric acid at the starting pH of 1.8 were titrated with NaOH (1.0 M) to match pHs 
of 2.5, 3.5, 5.0 and 7.0. 
3.2.2 Instrumentation 
The separation experiments of cathinone standards and commercial samples were 
performed using a fully automated capillary electrophoresis system (G1600, Agilent 
Technologies, Santa Clara, CA, USA) with the column temperature maintained at 25 °C. 
Separations were performed in 50 µm ID uncoated fused silica capillaries with a total 
length of 57.5 cm and an effective length of 49.5 cm. The capillary columns were 
obtained from Polymicro (Phoenix, AZ, USA). Prior to use, each new capillary was 
rinsed with 1.0 M NaOH for 25 min and water for 10 min as the pretreatment steps. 
Samples were introduced into the capillary using electrokinetic injection for 10s at 10 kV. 
CE-UV detection was performed via on-column measurements using a diode array 
detector (DAD) at a wavelength of 206 nm. Experiments were carried out in “normal 
polarity” mode (anode at the capillary inlet) by applying a constant voltage of 25 kV 
during analyses with the current at ∼52 µA. 
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3.3 Results and Discussion 
3.3.1 Method development and CE-UV results 
In this CE-UV study the cathinones examined belong to the benzoylethanamines 
class. These compounds have similar chemical structures differing from each other by 
presence of different substituents that may include halogen, dioxol, and alkyl groups. 
Hence, a highly efficient and selective method for the discrimination of such closely 
related compounds is needed. From the data reported in the literature, numerous 
chromatographic methods have been developed for the separation of this class of drugs. 
[102, 139-141]. However, given the wide variety and potential development of new 
compounds, there is a need for methods which can access the high efficiency and 
identification capability that can be obtained via CE and mass spectrometric methods. 
The initial conditions for the separation were adapted from a previous study 
developed in the McCord research group for the separation of amphetamine and 
piperazine designer drugs [142]. In that project, 6 piperazine and 4 chiral amphetamine 
compounds were simultaneously separated within 23 min using a 200 mM phosphate 
buffer at pH=2.8 with 20 mM hydroxypropyl-β-cyclodextrin (HP-β-CD) as a buffer 
additive. For the analysis of the cathinone analogs in this project, various separation 
parameters (pH, buffer concentration, field strength, etc.) were further optimized using 
UV-visible detection prior to coupling the procedure to mass spectrometry. 
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3.3.1.1 Background electrolyte (BGE) optimization 
Different pH conditions were tested at pH 2.5, 3.5, 5.0, and 7.0. It appears that at 
low pH the resolution was higher, presumably resulting from the reduced electroosmotic 
flow at low pH conditions. The results shown in Figure 3.3 illustrate the influences of the 
pH on the resolution and the analysis time. At higher pH conditions the resolution 
dropped, and coelution of several of the cathinones occurred. pH of 2.5 produced optimal 
migration times, peak efficiency, and resolution. Buffers at pH lower than 2.5 produced 
no advantage in terms of resolution of the peaks. Thus, pH of 2.5 was used for all further 
experiments.  
The effect of buffer concentration on the separation was examined at 50 mM, 75 
mM, 100 mM and 150 mM phosphate. Among these different concentrations, 100 mM 
phosphate provided the optimum results in terms of resolution and migration time.  
Once the pH and the buffer concentration were optimized, further tests were 
performed to improve the separation.  In particular, the author examined the effect of the 
addition of 5-20 mM β-cyclodextrin (β-CD) with and without organic modifiers in the 
buffer (Figure 3.4 and Figure 3.5). The results shown in Figure 3.4 demonstrate that the 
concentration of the β-CD has a marked effect on both of the resolution and the migration 
time. Higher concentrations of β-CD resulted in increased migration times due to slower 
migration of the drug/cyclodextrin complex. Optimal resolution and peak shape occurred 
at a concentration of 10 mM β-CD.  In addition to β-CD, highly sulfated-γ-CD (HS-γ-CD) 
and mixtures of HS-γ-CD and β-CD were examined (Figure 3.6). In general, the 
separations obtained from HS-γ-CD separation were not as efficient as those from β-CD.  
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Higher amounts of HS-γ-CD also lead to raised baselines and a significant drop in signal 
to noise ratio with UV detection.  The effects of 2 %, 5 %, and 10 % of MeCN, MeOH, 
and isopropanol in the BGE containing 10 mM β-CD were also tested. Bulk migration 
times were slower when organic modifiers were added to the BGE, and a decrease in the 
resolution of cathinones was observed. Because of the longer analysis time and the lower 
resolution, those conditions were not useful. Thus, the final conditions for the separation 
buffer consisted of 100 mM phosphate at a pH of 2.5 with 10 mM β-CD.  This buffer 
permitted the resolution of all relevant synthetic cathinones as well as the chiral 
separation of 10 of them (Figure 3.7). These buffer conditions compare favorably with a 
previous chiral separation of some of these compounds and uses neutral β-CD as a 
modifier [107]. 
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Figure 3.3 Effect of pH value on the separation of the twelve synthetic cathinones. (a) 
pH 2.5; (b) pH 3.5; (c) pH 5.0; (d) pH 7.0. Conditions: BGE 100 mM phosphate buffer; 
voltage injection, 10 kV for 10 sec; applied voltage, 25 kV; temperature, 25 ºC; fused-
silica capillary, 57.5 cm (49.0 cm effective length) x 50 μm i.d.; detection, 206 nm. 
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Figure 3.4 Effect of the concentration of β-cyclodextrine on the separation of the twelve 
cathinones and enantiomers. (a) 5 mM, (b) 10 mM; (c) 15 mM and (d) 20 mM. 
Separation conditions as in Figure 3.3.  
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Figure 3.5 Effect of the organic modifier as an addition to the phosphate buffer on the 
separation of the twelve cathinones and enantiomers. Separation conditions as in Figure 
3.3.  
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Figure 3.6 Effects of concentration of β-CD and HS-β-CD on the separation of the 
twelve cathinones and enantiomers. Separation conditions as in Figure 3.3.  
3.3.1.2 CE-UV results 
Figure 3.7 demonstrates the separation of a standard containing 12 cathinone 
analogs using this method.  The optimal running voltage was 25 kV (435 V/cm). Lower 
field strengths provided longer migration times and broader peaks, with little 
improvement in terms of resolution. 
The separation conditions utilized were the optimized parameters discussed in 
previous sections. A mixture of 12 compounds at 100 ng/mL for each individual 
compound was enantio-separated using a 100 mM phosphate buffer containing 10 mM of 
β-cyclodextrin at pH 2.5. Electrokinetic injection was used and the sample was injected 
for 10 s at 10 kV. The running voltage was 25 kV with cartridge temperature set to 25 ºC. 
A fused-silica capillary with 57.5 cm long (49.0 cm effective length) x 50 μm i.d. was 
used to carry out the separation. DAD was set to scan at 206 nm. 
All compounds except 4-fluoromethcathinone and methedrone showed 
stereospecific interactions with the chiral selector β-CD. 4-Fluoromethcathinone and 
methedrone could be distinguished from other compounds but could not be enantio-
separated. Interestingly, these two compounds were enantiomerically separated using the 
highly sulfated-γ-cyclodextrin buffer in CE-MS mode. Thus, the geometry of these 
molecules may have been a factor affecting the separation of their enantiomers by the 
different cyclodextrins.  
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Figure 3.7 Electropherogram of the simultaneous chiral separation of a mixture of 12 
compounds at 100 ng/mL, using a 100 mM phosphate buffer adding with 10 mM of β-
cyclodextrin. Separation conditions as in Figure 3.3. Peak identification: 4-
Fluoromethcathinone (1); Dimethylcathinone (2,2’); Ethcathinone (3,3’); Buphedrone 
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(4,4’); Pentedrone (5,5’); Methedrone (6); Methylone (7,7’); Mephedrone (8,8’); 
Ethylone (9,9’); 3,4-DMMC (10,10’); Pentylone (11,11’); MDPV (12,12’). 
3.3.2 Method validation 
Once the optimum conditions for the analysis of cathinones were determined, the 
method was validated in terms of linearity, precision, limit of detection (LOD), and limit 
of quantification (LOQ). Linearity of the method was established over the range from 
12.5 ng/mL to 500 ng/mL (n=5) with correlation coefficients (r2) ranging between 0.9911 
and 0.9955. Table 3.1 illustrates the analytical figures of merit obtained from the twelve 
analyzed synthetic cathinones.  
The analytical precision was assessed by examining repeated injections of a 
mixture of cathinones at a concentration of 100 ng/mL. In Table 3.1, inter-day and intra-
day precision data, including % RSD, migration time (tm), and peak areas, are reported as 
well. The RSD values for retention time were lower than 0.99% for intra-day precision 
and 1.0% for inter-day precision. Good results were also achieved for peak areas with 
RSD ≤ 7.6% and 8.5% for intra- and inter-day experiments. To investigate the method 
sensitivity under the proposed conditions, limits of detection (LOD) and quantification 
(LOQ) were determined as 3 times and 10 times the signal-to-noise ratio, respectively. 
The LODs ranging from 4.2 ng/mL to 7.0 ng/mL and LOQs ranging from 13 ng/mL to 21 
ng/mL for all selected cathinones were found (results shown in Table 3.1). 
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Table 3.1.Figures of merit for the CE-UV results of the chiral separation project 
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3.4 Concluding Remarks 
This chapter details the development of an optimized method for the separation of 
12 cathinone analogs using β-cyclodextrin for the CE-UV detection. Separations were 
carried out in 50 µm ID uncoated fused silica capillaries with a total length of 57.5 cm 
and an effective length of 49.5 cm. Electrokinetic injection mode was used for sample 
injection with conditions of 10 kV and 10 s. Running voltage was set to 30 kV. Various 
parameters were tested to obtain optimum separation results, including different chiral 
selectors, buffer concentrations, pH of the buffer, and organic modifiers. The β-CD was 
selected and optimum separation results were achieved using 100 mM phosphate buffer 
containing 10 mM of β-CD. All 12 cathinone analogs were separated with 10 out 12 
enantio-separated. 
The method provides high resolution separation by CE-UV. The protocol was 
validated by running various standards intra- and inter- day. The low injection volume 
permitted by CE will make this method useful in forensic laboratories when a minimal 
sample input is required. 
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CHAPTER 4 IDENTIFICATION OF CATHINONE ANALOGS BY TIME-OF-
FLIGHT MASS SPECTROMETRY 
 
4.1 Introduction 
Mass spectrometry (MS) is a technique that provides mass spectra information on 
atoms or molecules. In this study, I would like to take advantage of MS to identify the 
analytes in the project. Several factors are considered. The most vital step is to avoid 
ionization source contamination. To achieve the goal, partial filling technique was used. 
Partial-filling micellar electrokinetic chromatography (PF-MEKC) was first introduced 
by Terabe et al. [19] and provides a potential solution for interfacing chiral MEKC 
separations with ESI-MS. In comparison with conventional MEKC, PF-MEKC involves 
filling a small portion of the capillary with a micellar solution to achieve a separation. 
The capillary in PF-MEKC is filled with electrophoresis buffer, followed by the 
introduction of micellar solution and finally a sample injection. In PF-MEKC, the 
analytes first migrate into the micellar plug where the separation occurs and then into the 
electrophoresis buffer, which is free of surfactant. The analytes in the electrophoresis 
buffer sequentially elute out of the MEKC capillary and are subsequently introduced into 
ESI-MS, while the surfactant plug remains behind in the capillary. Once the analytes are 
detected by the mass spectrometer, electrophoresis is terminated to avoid the surfactant 
plug eluting into the detector. The partial filing technique has proven to be a very useful 
procedure to prevent nonvolatile chiral selectors entering into the MS. However, it 
requires a complex series of steps to avoid MS contamination. Molina et al. [143] 
61 
 
reported three ways to couple micellar electrokinetic chromatography (MEKC) on-line 
with electrospray ionization mass spectrometry (ESI-MS) for the analysis of N-
methylcarbamate pesticides. A more stable electrospray performance was obtained; 
however, some of the analytes were protonated and could not be detected due to the 
increase in their retention factors. 
 
Figure 4.1 Schematic view PF-MEKC (B) Background electrophoresis buffer; (S) 
surfactant in background electrophoresis buffer. Adapted from Ref. [144].   
Although novel MEKC-based methodologies have recently been proposed for 
chiral analysis, the combination of MEKC methods with MS detection still has some 
critical issues. One of the main limitations of this coupling is the lack of compatibility of 
the most widely used surfactants in MEKC separation with mass spectrometers [143]. 
Generally, surfactant monomers suppress the ionization of the analyte in the spray 
chamber, which in turn, provides an increased chemical noise in the electrosprays, 
reducing the sensitivity of the whole MS analysis. In last few years the use of high-
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molecular-mass micelle polymers (also referred to as micelle polymers or molecular 
micelles) as pseudo-stationary phase have been shown to be an interesting alternative to 
more conventional micelles for the analysis of enantiomers with MS. Further 
investigation of PF-MS will be examined to see if such materials would be appropriate 
for trace drug detection and chiral analysis. 
4.2 Experimental 
4.2.1 Chemicals and materials 
Phosphoric acid and acetic acid were purchased from Fisher Scientific (Pittsburgh, 
PA, USA); ammonium acetate, ammonium dihydrogen phosphate, ammonium formate, 
sodium phosphate monobasic monohydrate, and sodium hydroxide from Sigma-Aldrich 
(St. Louis, MO, USA); β-cyclodextrin from TCI America (Portland, OR, USA); and 
highly sulfated γ-cyclodextrin from Beckman Coulter (Brea, CA, USA). Sodium 
phosphate dibasic heptahydrate were obtained from Acros Organics (Morris Plains, NJ, 
USA). Development of capillary electrophoresis as part of a micro-total analytical system 
for microcystins 
Acetonitrile (ACN), methanol (MeOH), Isopropanol, and phosphoric acid used 
for the preparation of the buffer electrolytes, were of analytical reagent grade (Carlo Erba, 
Milan, Italy). Distilled water was deionized by a Milli-Q water purification system 
(Millipore, Bedford, MA, USA).  
Drug standards of (±)-2-(methylamino)-1-phenylbutan-1-one (Buphedrone), (±)-
1-phenyl-2-(methylamino)pentan-1-one (Pentedrone), (±)-1-(4-methoxyphenyl)-2-
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(methylamino)propan-1-one (Methedrone), (±)-1-(3,4-dimethylphenyl)-2-
(methylamino)propan-1-one  (3,4-DMMC), (±)-2-ethylamino-1-phenyl-propan-1-one 
(Ethcathinone), (±)-1-(4-fluorophenyl)-2-methylaminopropan-1-one (4-
Fluoromethcathinone), (±)-2-dimethylamino-1-phenylpropan-1-one (Dimethylcathinone), 
(±)-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (Ethylone), (±)-1-(1,3-
benzodioxol-5-yl)-2-(methylamino)pentan-1-one (Pentylone), and (±)-2-(ethylamino)-1-
phenyl-1-propanone, monohydrochloride (Ethcathinone) were purchased from Cayman 
Chemical (Ann Arbor, MI, USA) and drug standards of (±)-2-methylamino-1-(4-
methylphenyl)propan-1-one (Mephedrone), (±)-1-(Benzo[d][1,3]dioxol-5-yl)-2-
(pyrrolidin-1-yl)pentan-1-one (MDPV) and (±)-2-methylamino-1-(3,4-
methylenedioxyphenyl)propan-1-one (Methylone) were purchased from Lipomed 
(Cambridge, MA, USA). The chemical structures of cathinones are represented in Figure 
2.1b. 
4.2.2 Background electrolyte preparation 
Phosphate buffers were prepared by weighing out appropriate amount of sodium 
phosphate monobasic monohydrate salt and sodium phosphate dibasic heptahydrate salt 
to pH at 4.5, 6.0, 7.0, and 8.0. For low pH conditions, phosphate buffers were prepared 
by diluting concentrated phosphoric acid to a 100 mM phosphate buffer and adjusting pH 
with a 1.0 M NaOH solution in order to reach the desired pH to 2.5 and 3.5. 
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4.2.3 Sample preparation 
Stock solutions of synthetic cathinones (0.1 mg/mL) were prepared in methanol 
and stored at -20 °C. Background electrolytes (BGE) used for CE-MS experiments were 
prepared daily by dissolving the proper amount of highly sulfatedγ-cyclodextrins in 
phosphate buffer. All the electrolyte solutions for the CE-MS separation were stored in 
glass bottles at + 4 °C. 
Seized drug samples were obtained from law enforcement sources previously 
diluted to an appropriate concentration in methanol (approximately 1mg/mL) and 
centrifuged to remove insoluble material. 
4.2.4 Instrumentation 
The separation of cathinone standards and commercial samples was performed 
using a fully automated CE system (G1600, Agilent Technologies, Santa Clara, CA, USA) 
with the column temperature maintained at 25 °C. Separations were performed in 50 µm 
ID uncoated fused silica capillaries with a total length of 80 cm.  The capillary columns 
were obtained from Polymicro (Phoenix, AZ, USA). Each new capillary was rinsed with 
1.0 M NaOH for 25 min and water for 10 min. Samples were introduced into the capillary 
using electrokinetic injection for 10s at 10 kV. Experiments were carried out in “normal 
polarity” CE mode (anode at the capillary inlet) by applying a constant voltage of 25 kV 
during analyses. 
The time of flight mass spectrometry (TOF-MS) analysis was performed in the 
positive ion mode using partial filling technique [145-148] to minimize contamination of 
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the MS with non-volatile cyclodextrins. The CE system was connected to a TOF-MS, 
(3250a MSD, Agilent Technologies, Santa Clara, CA, USA) with a CE-ESI-MS sprayer 
interface. Reference masses obtained from Agilent (G1969-85001 API-TOF reference 
mass solution kit) including purine at 121.0509 m/z and HP0921 at 922.0098 m/z were 
added to the sheath flow liquid to calibrate the mass spectrometer. The mass range was 
set to 100-1000 m/z to include both reference masses. The sheath flow – which was 
composed of 50:50 (v/v) deionized water and methanol along with reference mass 
solutions – was provided by an isocratic pump set to a low rate of 0.5 mL/min with a 
1:100 split ratio resulting in a net flow of 0.005 mL/min. 
Table 4.1 CE-ESI-TOF-MS parameters for chiral analysis of cathinone analogs 
Parameter Value 
Capillary Voltage 4000 V 
Nebulizer pressure 10 psi 
Drying gas 5 L/min 
Gas temperature 250 °C 
Fragmentor voltage 125 V 
Skimmer voltage 40 V 
Octapole RF 300 V 
TOF/PMT 1025 V 
Mass range (m/z) 0-1000 
Sheath flow 0.5 mL/min 
Reference 121.0509, 922.0098 
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4.3 Results and Discussion 
4.3.1 Method development and CE-MS results 
To couple the CE with the TOF-MS detector, the capillary was extended to 80 cm 
in total length to reach the ESI interface. An Agilent Time-of-Flight (G1969A) mass 
spectrometer was employed for CE-MS detection. 
4.3.1.1 Buffer selection 
For capillary electrophoresis- mass spectrometry technique, a volatile buffer 
should be used in order to avoid mass sprayer contamination [149]. Ammonium acetate 
and ammonium formate were initially tested as background electrolyte because both are 
volatile and have similar pKa and buffer ranges to the phosphate buffer used in the CE-
UV method [149]. However, the separations produced by the ammonium acetate and 
ammonium formate buffers were poor. Therefore, to maintain acceptable separation 
results, non-volatile phosphate buffer was adopted; however, the concentration of 
phosphate buffer was reduced to 50 mM. It should also be noted that this level of buffer 
was further diluted by the addition of the sheath flow prior to introduction to the mass 
spectrometer [150, 151]. To further minimize contamination of the mass spectrometer, 
which was biased in the positive mode, the β-cyclodextrin in the UV separation was 
replaced by highly sulfated-γ-cyclodextrin [152]. In previous work, highly sulfated γ-
cyclodextrin has exhibited good enantiomeric separation ability [153-156] and the highly 
sulfated form should migrate counter to the osmotic flow in the capillary. 
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Several parameters, including pH and the concentration of cyclodextrin, were 
investigated in order to obtain optimal separations.  As expected, the optimal pH of 2.5 
was similar to that found for the CE-UV. For chiral selection, different amounts of highly 
sulfated-γ-cyclodextrin were tested starting with 0.2%. Experiment results indicated that 
0.6% was the optimum concentration. At concentrations  of  highly sulfated-γ-
cyclodextrin lower than 0.6%, some peaks could not be separated; at concentrations 
higher than  0.6%, excess noise was present in the extracted ion chromatogram 
presumably because small amounts of highly sulfated-γ-cyclodextrin entering  into 
electrospray ionization source.   
Interestingly, the results using highly sulfated-γ-cyclodextrin produced different 
separation dynamics.  Previously unresolved enantiomeric separations of methadrone and 
fluormethcathinone in CE-UV experiments (Chapter 3) were achieved with the new 
conditions, while other compounds previously separated as enantiomers such as 
methylone, dimethyl cathinone, ethcathinone, pentedrone and buphedrone were not. 
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Figure 4.2 Buffer selection: ammonium acetate vs. phosphate. 
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            The final two buffer candidates are phosphate and ammonium acetate. The 
comparison of these two buffers are shown as Figure 4.2. Two aspects are compared, first 
from the angle of peak shapes in electropherogram, which represents resolution and 
sensitivity.  As shown in Figure 4.2, ammonium acetate demonstrates smooth peak shape. 
Secondly, the separation windows of the two buffers are compared. Phosphate buffer 
provides longer separation window, which can be treated as better separation ability in 
terms of selectivity. 
            Considering the chiral separation project is mainly focused on the separation, the 
author decided to choose the phosphate buffer because of its better separation ability. 
Table 4.2 Effect of amount of HS-γ-CD filled in the capillary on peaks. Values are given 
as percentage in relation to the value for 70% (56 cm) partial filling 
 
Amount of HS‐γ‐CD Baseline Noise (%) Sensitivity (%)
90% (72 cm) 139 75
80% (64 cm) 120 82
70% (56 cm) 100 100
60% (48 cm) 92 109
50% (40 cm) 87 115
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4.3.1.2 Optimization of MS conditions 
Once proper separation parameters were established, MS detection parameters 
were optimized for the cathinone analogs. Samples were directly infused into the mass 
spectrometer and scanned at different voltages in the positive electrospray ionization 
mode. To optimize ESI ionization, different voltages were applied to the ion optics. 
Among the mass spectrometry parameters tested were capillary voltages from 3000 to 
4500 V, fragmentor voltages from 110 to 225 V, and skimmer voltages from 40 to 110V. 
The combination providing the best performance for compounds separated in the positive 
ion mode was 4000 V, 225 V and 50 V for the capillary, the fragmentor, and the skimmer 
respectively. Optimum conditions are demonstrated in Table 4.2. 
Next, the CE and MS were connected together employing the optimum conditions 
described above. All of the compounds which could be separated in CE-UV mode were 
also separated and identified by CE-MS mode, though the elution order was different due 
to the change from neutral to charged cyclodextrins in the buffer. Since different 
cyclodextrins were employed in CE-UV and CE-MS, the separation results were 
expected to be slightly different. For instance, in the CE-MS experiments, Compound 1, 
4-fluoromethcathinone and Compound 6, methedrone were enantomerically separated by 
HS-γ-CD while in the CE-UV experiments using β-CD both compounds were eluted as a 
single peak. Similarly, certain compounds separated enantiomericaly by β-CD were not 
fully separated by HS-γ-CD; for example, Compound 2 dimethylcathinone. 
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4.3.1.3 Partial-filling (PF) technique 
The partial filling technique [145, 146] was employed in the CE-MS procedure to 
reduce contamination by the non volatile cyclodextrin assisted phosphate buffer. With 
partial filling, the HS-γ-CD buffer was aspirated into a fraction of the capillary instead of 
fully flushing the capillary. By doing so, the non-volatile portion of the buffer does not 
enter the mass spectrometer. To start with, the 80 cm capillary previously filled with 
phosphate buffer was filled with 50% (40 cm), 60% (48 cm), 70% (56 cm), 80% (64 cm) 
and 90% (72 cm) of its length with the phosphate buffer containing HS-γ-CD. Overall the 
70% filling exhibited the best separation results and the lowest baseline noise. While the 
procedure reduces the overall separation efficiency in an amount proportional to the fill 
length, the baseline noise of the mass spectrometer is reduced by 45%. 
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Figure 4.3 Different partial filling percentage (length of buffer filled in capillary divided 
by total length of capillary) 
4.3.1.4 TOF-MS results  
Figure 4.4 illustrates the extracted ion chromatogram of 12 cathinone analytes 
using the optimized CE-MS separation conditions. Compounds which have same 
molecular weight and thus the same mass to charge ratio, are extracted in the same pane. 
The twelve analytes are divided into eight groups with masses ranging from 178 to 276 
Daltons. The number of each compound is the same as in UV experiment in Figure 3.7. 
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Figure 4.4  Extracted Ion Chromatograms at specific m/z of a mixture of 12 cathinone 
analytes at 0.5 µg/mL each using 50 mM pH 2.5 phosphate buffer with 0.6% (v/v) highly 
sulfated-γ-cyclodextrin, CE conditions: running voltage 25 kV, 5 kV for 10s injection, 
TOF-MS conditions: source temperature = 250 °C, drying gas = 5 mL/min, nebulizer 
pressure = 10 psig, positive ion mode (ESI+), capillary = 3000 V, fragmentor = 125 V, 
skimmer = 40 V. Peak identification: 4-Fluoromethcathinone (1,1’); Dimethylcathinone 
(2); Ethcathinone (3); Buphedrone (4); Pentedrone (5); Methedrone (6,6’); Methylone 
(7,7’); Mephedrone (8,8’); Ethylone (9,9’); 3,4-DMMC (10,10’); Pentylone (11,11’); 
MDPV (12,12’). The masses listed on the chromatogram are experimental values. See 
Table 4.3 for calculated values and mass errors. 
Table 4.3 presents the exact mass measurements obtained by ESI-TOF-MS 
detection. The theoretical [M+H] values were calculated and compared with the 
experimental values. Mass errors in terms of Daltons and ppm are reported. The 
experimental values, relative standard deviations of the experimental values, and mass 
errors are calculated for experiments performed at 0.5 μg/mL using optimum separation 
conditions. n=5. 
Table 4.4 demonstrates the linearity and sensitivity data for CE-MS results. 
Correlation coefficients, LODs and LOQs are calculated for all analytes, with 1.0 ng/mL 
to 11 ng/mL for LOD and 3 ng/mL to 33 ng/mL for LOQ. Comparing to the figures of 
merit for CE-UV, the MS detector provides lower LODs for 9 out of 12 analytes. Table 4 
also illustrates the precision for the CE-MS procedure. Intra- and inter-day data were 
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analyzed and presented in the table. It should be noted that linearity could be further 
improved through the use of an internal standard [154]. 
Table 4.3 CE-ESI-TOF-MS accurate mass measurements for chiral analysis of cathinone 
analogs 
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Table 4.4 Figures of merit for the CE-ESI-TOF-MS results 
 
4.3.2 Analysis of seized drug samples 
Bath salts are commonly used in various situations, both legally and illegally. In 
Florida, bath salts are a commonly used illicit drug of abuse [90, 157]. To examine the 
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capabilities of the previously mentioned procedure, eight previously analyzed seized drug 
samples were provided by Broward Sheriff’s Office for analysis via CE-MS method and 
comparison with a previously validated GC-MS method. All of the tested samples 
contained methylone (m.w. 207.0892). One sample contained 3,4-
Dimethylmethcathinone (3,4-DMMC, m.w. 191.1306) as well. Analyses of two of these 
samples are shown in Figure 4.5 and Figure 4.6.  
The results of CE-MS match those obtained using of GC-MS from Broward 
Sheriff’s Office, and also provide exact mass measurements to assist in the identification 
process.  Methylone is currently a Schedule I controlled substance in State of Florida 
which is prohibited for use in medical treatments [158]. 
 
Figure 4.5 Sample A:  TOF-MS Extracted Ion Chromatogram (top) and mass spectrum 
showing peak m/z 208.0968 (bottom). 
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Figure 4.6 Sample B:  TOF-MS Extracted Ion Chromatogram (top) and mass spectrum 
showing peaks m/z 192.1354 and m/z 208.0952 (bottom). 
4.4 Concluding Remarks 
This chapter demonstrates the development of an optimized method for the 
separation of 12 cathinone analogs using CE-TOF-MS. Experiments were performed in 
50 µm I.D. uncoated fused silica capillaries with a total length of 80 cm. The running 
voltage was set to 25 kV. The procedure was adapted from utilizing β-cyclodextrin for 
CE-UV separation and optimized with highly sulfated γ-cyclodextrin for CE-MS 
detection. Initial attempts to use volatile buffers to improve the coupling of the MS to the 
CE system. However, the separation ability of volatile ammonium acetate and 
ammonium formate was not as good as the non-volatile phosphate buffer in terms of 
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selectivity. Thus, the use of the phosphate buffer was continued but the concentration was 
decreased from 100 mM in the CE-UV mode to 50 mM in the CE-MS mode. Meanwhile, 
HS-γ-CD was examined and employed instead of β-CD to avoid contamination of the 
mass spectrometer’s ion source. Since HS-γ-CD is a negatively charged chiral selector, it 
was expected to migrate counter to the ion current which was set to be towards the anode.  
As a result, the potential for contamination of the MS ion source by non-volatile CD is 
greatly reduced. Lastly, a partial filling technique was used to further reduce the 
possibility of MS ion source contamination. Different percentages of partially filled 
capillaries were tested. A capillary with 70% full of phosphate buffer containing chiral 
selector was used to perform the experiment.  
The method developed provides exact mass identification of individual analytes 
present in the mixture by TOF-MS. The procedure was tested using a small set of seized 
illicit bath salt samples obtained from law enforcement. The results of this study matched 
previously obtained data by GC/MS. Overall this method presents a useful procedure for 
separation and analysis of chiral cathinones. The low injection volume permitted by CE 
will make this method useful in forensic laboratories when a minimal sample input is 
required. Exact mass detection permits the determination of unknown compounds.  To 
the author’s knowledge, this is the first report of cathinone analogs separated and 
detected by both CE-UV and CE-TOF-MS. 
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CHAPTER 5 MICROCYSTIN AND CAPILLARY ELECTROPHORESIS MASS 
SPECTROMETRY: AN ENVIRONMENTAL APPLICATION 
5.1 Introduction 
5.1.1 Cynobacteria and microcystin 
Cyanobacteria, also known as cyanophyta or blue green algae, are prokaryote 
photosynthetic organisms, which lack membrane-bound organelles and sexual 
reproduction [159-161]. The occurrence of cyanobacteria on the earth can be traced back 
for at least over 2.7 billion years. Cyanobacteria were the first organisms to have the 
ability to produce oxygen gas (O2) as a by-product of photosynthesis [162], which is 
considered to have converted early atmosphere into an oxidizing one, leading to dramatic 
change in the composition of life forms on earth. Cyanobacteria can process 
photosynthetic nitrogen fixation by converting nitrogen (N2) in the atmosphere  into 
ammonium (NH4),  nitrites (NO2-) or nitrates (NO3-), which can be further converted into 
protein and nucleic acid for the simplest nutritional requirements of all living organisms 
[159]. Cyanobacteria also use the energy of sunlight to initiate photosynthesis for carbon 
fixation, the process which generally involves the conversion of inorganic carbon to 
organic compounds.  
Cyanobacteria are widely distributed throughout the world, reflecting their 
genotypic and phenotypic variation [159]. They are commonly found in diverse types of 
every terrestrial habitat, including oceans, lakes, fresh water, deserts, and even in the 
extreme environment of Antarctica and thermal springs. The predominant habitats of 
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cyanobacteria are freshwater and marine environments, in which extensive and highly 
visible blooms can form. Theses harmful algae blooms are formed under favorable 
conditions, such as high temperatures, high pH, and intense light; they enhance the 
available nutrients released by athropogenic activities [163, 164].  
Certain cyanobacteria produce highly toxic secondary metabolites known as 
cyanotoxins, which are a severe threat to human and animal health as well as to the 
environment. Ingestion of water or food contaminated by cyanotoxins can lead to severe 
diseases such as acute gatro-intestinal disorder [164], inhalational problems, and death 
for humans and animals. Dermal exposure to the cyanotoxins also has the risk of acute 
skin irritant effects such as acute skin eruptions [165, 166]. Cyanobacteria can produce a 
range of cyanotoxins with structural diversity and biological activity differences, such as 
microcystins, cylindrospermopsins, saxtoxins, and domoic acid (Figure 5.1). 
 
 
Figure 5.1 Structures of some cyanobacteria 
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One of the most problematic cyanotoxins is microcystin, a cyclic peptide toxin 
with seven amino acids and a cyclo (D-Glu-MDHA-D-Ala-L-Leu-D-Asp-l-Arg). 
Microcystin contains a unique non-protein amino acid, 3-amino-9-methyoxy-2,6,8-
trimethyl-10-phenyldeca-4,6-dienoic acid, also known as ADDA [166], which is critical 
for biological activity. Microcystin is also considered to be a hepatotoxin and is produced 
by various genera of freshwater cyanobacteria, such as microcystis, anabaena, nostoc, 
and oscillatoria [167, 168]. The general mechanisms of hepatotoxin are related to the 
inhibition of protein synthesis [169]. For example, hepatotoxins can inhibit protein 
phosphatase enzymes (PP1 and PP2A) within liver cells, resulting in increased liver 
weight and modified plasma membranes [169].  Hepatotoxins can also cause damage of 
liver structure by hypovolemic shock and extra accumulation of blood in the liver [170].  
Microcystins impact aquatic ecosystems, especially aquatic invertebrates. 
Rohrlack et al. [171] studied the effects of ingestion of microcystins on Daphnia galeata 
and found that ingestion of the microcystin-producing PCC 7806 wild type cells leads to 
lethal poisoning. Chen et al. [172] also reported the effects of microcystin on Daphnia 
galeata and demonstrated that high concentrations and longtime exposure to microcystin 
were fatal, leading to the accumulation and inhibition of the enzyme phosphatase. 
Microcystin was also reported to be harmful to fish. Exposure to microcystin during 
feeding or breathing can lead fish to die. The paper published by Tencalla [173] indicated 
that microcystin transferring route in trout is via the gastrointestinal tract, and that 
toxicity is manifested as massive hepatic necrosis. 
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Human exposure to microcystin generally occurs through ingestion of microcystin 
contaminated water or food, or through a dermal route during recreational activities when 
harmful algae blooms. Besides the affected organs in the liver, other affected organs such 
as kidneys and colon cause illness as gastroenteritis, irradiant and allergic skin effects, 
and liver diseases. Human exposure to low but long-term concentrations of microcystin 
can cause chronic diseases, such as tumors and cancers, which are related to the toxicity 
of microcystin. Therefore, the World Health Organization (WHO) established a 
maximum value of 1 ppb for microcystin-LR in drinking water in 1997 [169, 174]. 
The first notable incident of microcystin toxicity on human health was discovered 
in the town of Caruaru in Brazil in 1996, which led to 76 deaths from liver complications 
due to intake of contaminated water. The symptoms of these patients were headache, eye 
pain, blurred vision, nausea, and vomiting. Further analysis and determination found the 
existence of microcystin in blood and liver of patients [175]. Other cases involving 
human poisoning by microcystin toxicity have also been reported. In England, two 
canoeing exercisers drank microcystin contaminated water, which lead to left basal 
pneumonia for four to five years [176]. Another accident occurred in Brazil where the 
poisoning resulted from the blooms of anabaena and microcystin freshwater genera. This 
poisoning incident led to gastroenteritis in 2,000 people and 88 deaths over a period of 42 
days [169]. 
5.1.2 Current analytical approaches for microcystin detection 
Many scientific studies have been published for separation and identification of 
various microcystin family compounds using different analytical instrumentation and 
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methods, including HPLC / HPLC-MS [177-180], GC / GC-MS [181-183], and TLC 
[184-186]. However, these methods suffer from either tedious sample pretreatment 
procedures or low sensitivity. Capillary electrophoresis has been widely used for 
separation and detection of microcystin variables because of its simplicity, low sample 
volume requirement, and high sensitivity [180, 187-190]. 
Gabor Vasas et al. [191] reported separation of three cyanotoxin compounds 
(ANA-a, MCY-LR, and CYN). Both CZE and MEKC methods were examined and 
different parameters were tested. The authors presented optimum separation conditions 
with borate buffer at high pH conditions for CZE and sodium tetraborate containing SDS 
for MEKC. All three compounds were separated within 4 min in the CZE mode. 
However, buffers containing SDS are not suitable for coupling CE with the MS detector, 
as the nonvolatile detergent may contaminate the MS ion source. 
E.C. Aguete et al. [192] demonstrated a procedure for separating three cyanotoxin 
analytes (RR, LR, and YR) by HPLC and HPCE. Samples were pretreated using 
immunoaffinity extraction. All three compounds were separated within 20 min in both 
the HPLC and HPCE modes. 
The goal of this project is to develop a method which allows rapid separation and 
detection of various microcystin compounds with CE separation with coupling to both the 
UV/Vis and MS detectors. To the author’s knowledge, this is the first report where the 
three microcystins MC-RR, MC-YR, and MC-LR have been separated within 6 min 
using both CE-UV and CE MS techniques. 
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5.2 Experimental 
5.2.1 Chemicals and materials 
Phosphoric acid and acetic acid were purchased from Fisher Scientific (Pittsburgh, 
PA, USA); ammonium acetate, ammonium dihydrogen phosphate, ammonium formate, 
sodium phosphate monobasic monohydrate, and sodium hydroxide from Sigma-Aldrich 
(St. Louis, MO, USA); β-cyclodextrin from TCI America (Portland, OR, USA); highly 
sulfated γ-cyclodextrin from Beckman Coulter (Brea, CA, USA); and sodium phosphate 
dibasic heptahydrate from Acros Organics (Morris Plains, NJ, USA).  
Acetonitrile (ACN), methanol (MeOH), isopropanol, and phosphoric acid used for 
the preparation of the buffer electrolytes, were of analytical reagent grade (Carlo Erba, 
Milan, Italy). Distilled water was deionized by a Milli-Q water purification system 
(Millipore, Bedford, MA, USA). 
5.2.2 Instrumentation 
The separation of cathinone standards and commercial samples was performed 
using a fully automated CE system (G1600, Agilent Technologies, Santa Clara, CA, USA) 
with the column temperature maintained at 25 °C. Separations were performed in 50 µm 
ID uncoated fused silica capillaries with a total length of 50 cm.  The capillary columns 
were obtained from Polymicro (Phoenix, AZ, USA). Each new capillary was rinsed with 
1.0 M NaOH for 10 min and water for 5 min. Samples were introduced into the capillary 
using electrokinetic injection for 15s at 10 kV. CE-UV detection was performed via on-
column measurements using a diode array detector (DAD) at a wavelength of 206 nm. 
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The time of flight mass spectrometry (TOF-MS) analysis was performed in the 
positive ion mode using partial filling technique [36-39] to minimize contamination of 
the MS with non-volatile cyclodextrins. The CE system was connected to a TOF-MS, 
(3250a MSD, Agilent Technologies, Santa Clara, CA, USA) with a CE-ESI-MS sprayer 
interface. Reference masses obtained from Agilent (G1969-85001 API-TOF reference 
mass solution kit), including purine at 121.0509 m/z and HP0921 at 922.0098 m/z, were 
added to the sheath flow liquid to calibrate the mass spectrometer. The sheath flow –
which was composed of 50:50 (v/v) deionized water and methanol along with reference 
mass solutions – was provided by an isocratic pump set to a low flow rate of 0.5 mL/min 
with a 1:100 split ratio, resulting in a net flow rate of 0.005 mL/min. 
5.3 Results and Discussion 
Detailed methodology of the project was presented in the thesis titled 
“Quantitative analysis and determination of microcystin in water by capillary 
electrophoresis mass spectrometry” by Bingxue Zheng in 2014 [193]. In short, four 
microcystin variables were separated within 6 min by phosphate buffer containing β-
cyclodextrin. Different separation conditions, such as pH, buffer ionic strength, and 
various organic modifiers were tested in the thesis of Zheng, B.. However, due to lack of 
confirmatory information provided by UV/Vis spectrometry, it is necessary to introduce 
another confirmatory method to identify the analytes. MS was widely used coupled with 
HPLC or CE for microcystin analysis [194-197]. 
In this chapter, the CE-MS portion of the project will be mainly discussed. 
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5.3.1 Volatile buffer consideration for MS detection 
When extending the capillary to the MS detector, the main consideration is how to 
avoid MS ion source contamination. The 100 mM phosphate buffer was utilized in the 
CE-UV part of the analysis; however, it was not advisable to continue using the same 
buffer, as 100 mM is too high a concentration for MS detector, and phosphate is a non-
volatile buffer. However, a number of studies [150, 151] have indicated that with the 
introduction of the sheath liquid, the concentration of the phosphate buffer could be 
further diluted to 1:100 ratio. Because of this consideration, phosphate buffer was 
employed; however, 50 mM buffer was prepared instead of 100 mM. Volatile buffers, 
such as ammonium acetate and ammonium formate, were also tested. However, their 
separation performance was not as good as with phosphate buffer. 
5.3.2 TOF-MS results 
Figure 5.2 represents the extracted ion chromatogram of three microcystin 
variables. As the figure shows, all three compounds were separated by 50 µm ID 
capillary and identified by TOF-MS within 6 min. Since TOF is an accurate mass 
analyzer, the molecular mass info was obtained to four decimal places, which is a 
powerful tool to accurately identify the analytes. 
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Figure 5.2 Extracted mass spectrum of MC-RR, MC-YR and MC-LR. 
 
Figure 5.3 Mass spectrum of MC-RR, MC-YR and MC-LR. 
Mass measurements are presented in Table 5.1. As shown in the table, low error 
in terms of amu and ppm was achieved with the TOF-MS system. It can be proved that 
TOF-MS is an accurate measurement method for analyte identification. 
 
 
MC‐RR:  R1 = Arg    
MC‐YR:  R1 = Tyr    
MC‐LR:  R1 = Leu    
89 
 
Table 5.1 Accurate mass measurements of the three microcystin analytes 
 
. 
5.4 Concluding Remarks 
This chapter presents a rapid and novel procedure for separation and identification 
of microcystin variables using capillary electrophoresis with mass spectrometry as a 
detection method. A 50 µm I.D. uncoated fused silica capillary with a total length of 70 
cm was used for the CE-MS experiments. Experiments were carried out using 25 kV as 
the running voltage. Phosphate buffer was used for the separation. Different pH, buffer 
concentrations, and various amounts of organic modifiers and chiral selectors were 
examined. The optimum separation results were achieved with 100 mM phosphate buffer 
at pH 8.0 with 10 mM β-CD adding to the buffer for the CE-UV part. For the CE-MS 
part, a 50 mM phosphate buffer at pH 7.5 without β-CD was utilized for optimum 
separation. All three microcystin analogs were separated within 6 min. Accurate 
molecular weight was obtained through TOF-MS, and mass errors were calculated. The 
method was applied to spiked microcystin samples and real environmental samples (pond 
water). 
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CHAPTER 6 OVERALL CONCLUSIONS 
This dissertation demonstrates several novel and advanced capillary 
electrophoretic techniques for forensic, pharmaceutical, and environmental applications. 
The idea of the overall work is to utilize the advantages of capillary electrophoresis 
coupling with mass spectrometric techniques over other hyphenated chromatographic 
techniques, i.e. gas chromatography mass spectrometry and liquid chromatography mass 
spectrometry. In order to accomplish my goals of separation and detection of chiral, 
neutral, and charged molecules by mass spectrometry, different procedures of capillary 
electrophoretic techniques – including monolithic capillary electrochromatography, 
capillary zone electrophoresis, and partial filling technique – were explored, examined 
and discussed in this dissertation. 
Chapter 1 introduces the background of the overall project, challenges, and 
problems existing in forensic, pharmaceutical, and environmental applications as well as 
general principles of capillary electrophoresis systems. 
Chapter 2 exhibits the principles of capillary electrochromatography and a novel 
development of monolithic CEC columns. Hexyl acrylate based monolithic columns were 
developed and optimized. A porous structure was built inside of 100 µm I.D. transparent 
capillary columns. Monomer solutions were prepared using different organic chemicals 
as described in the chapter and polymerized with UV lamp under 360 nm radiations. 
Various approaches were made to ensure the quality of the home-made capillary columns. 
This chapter details a method for separation and identification of six antidepressant 
compounds using an acrylate-based porous monolith capillary. Capillary 
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electrochromatography coupled with the UV detector was explored. The CEC-UV 
method provides an effective and efficient method for the separation and identification of 
the analytes. Spiked urine samples were utilized to check the capability of the method. A 
liquid-liquid extraction procedure was established to perform sample extraction. Time-of-
flight mass spectrometry was also employed for spiked urine sample analysis, and 
accurate molecular information was obtained. 
Chapter 3 explores an approach to fulfill enantioseparation of chiral compounds 
with adding cyclodextrin to the background electrolyte. Compared to HPLC, GC, or CEC 
methods, this method provided a simplified way to accomplish the chiral separation. In 
this chapter, a rapid chiral separation of 12 cathinone analogs has been developed and 
validated using cyclodextrin-assisted CE with UV and time of flight mass spectrometric 
(TOF-MS) detection. Optimum separation was obtained on a 57.5 cm × 50 µm capillary 
using a buffer system consisting of 10 mM β-cyclodextrin (β-CD) in a 100mM phosphate 
buffer for CE-UV. All analytes were separated within 18 minutes in the CE-UV mode. 
Ten compounds were enantiomerically separated using β-cyclodextrin. Detection limits 
down to 1.0 ng/mL were obtained. The method was then validated by analytical 
performing tests including LOD, LOQ, and RSD%. 
Chapter 4 demonstrates a CE-MS method of enantioseparation on the basis of CE-
UV procedures described in Chapter 3. In this study, time of flight mass spectrometric 
(TOF-MS) detection was employed to identify accurate mass information of 12 cathinone 
analytes. Time-of-flight mass spectrometry is a more accurate measurement than UV, 
because it can confirm the presence of a certain compound in the samples. Optimum 
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separation was obtained on a 80 cm × 50 µm capillary using a buffer system consisting of 
0.6% (v/v) highly sulfated-γ-cyclodextrin (HS-γ-CD) in a 50 mM phosphate buffer. In the 
CE-MS experiments, a partial filling technique was employed to ensure that a minimum 
amount of cyclodextrin entered the mass spectrometer in order to avoid contamination of 
the MS ion source. All analytes were separated within 18 minutes and identified by TOF-
MS. The CE-MS method was then applied to examine the seized drugs. 
Chapter 5 discusses the applications of capillary electrophoresis mass 
spectrometry in environmental toxicology using microcystin as an example. Microcystin 
belongs to cyanotoxin and has several different varieties. In this chapter, a rapid 
separation and identification method of four microcystin compounds was developed with 
a 50 µm ID capillary using a phosphate buffer as the background electrolyte. Compared 
to previous published methods, the procedure demonstrated in this chapter achieved fast 
separation within 6 min. In addition, accurate molecular information on each analyte was 
acquired with TOF-MS detection. 
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CHAPTER 7 FUTURE RESEARCH ON FORENSIC, ENVIRONMENTAL AND 
PHARMACEUTICAL APPLICATIONS BY ADVANCED CAPILLARY 
ELECTROPHORESIS TECHNIQUES 
 
Though capillary zone electrophoresis is a fairly simple form of electrophoretic 
technique, the increasing demand for achieving impressive separation efficiency makes 
scientists continue to optimize current approaches and explore new methods. In this 
chapter, I consider several ideas that could be of potential interest for research, which are 
presented below. 
7.1 Monolithic Chiral Stationary Phases 
Currently, the hexyl acrylate based monolithic column has been successfully 
applied for separation of neutral and charged small molecules as detailed in Chapter 2.  
As demonstrated in that chapter, monolithic CEC techniques can provide improved 
separation ability for neutral and charged small molecules. Future study can be conducted 
with further modification to the monolithic stationary phase in order to achieve the goal 
of chiral separation. Several monolithic chiral stationary phases have been developed for 
CEC. It is very important to focus on these chiral selectors, as many of the drugs and 
metabolites are chiral compounds which possess quite different pharmacodynamic 
characteristics [198]. Recent achievements using chiral stationary phases with CEC have 
been described in several review articles [82, 83, 199]. In order to prepare a chiral 
stationary phase, one approach is binding the most commonly used chiral selector 
94 
 
cyclodextrin to the silica wall of the capillary column. The proposed method is shown as 
Figure 7.1 [200-202]. 
The reaction starts with regular β-CD reacting with CH2CH(CH2)nBr in sodium 
hydroxide and DMSO condition.  The CH2CH(CH2)n group is added to one of OH group 
on the ring of CD. The intermediate product continues reacting with CH3I / NaH and 
dimethylsiloxone. The final product is synthesized. 
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Figure 7.1 Synthesis of chemically modified chiral polysiloxanes Chirasil-Dex. DMSO = 
dimethyl sulfoxide, DMF = dimethylformamide,polysiloxane = 
methylhydro/dimethylpolysiloxane 5/95. Adapted from Ref. [200]. 
7.2 Monolithic CEC Microchips 
In recent years, miniaturization has become an important topic across different 
scientific disciplines in the scientific world. The two main advantages of miniaturized 
devices currently attracting the attention of scientists are portability and low cost of 
fabrication. Different research groups have been working on miniaturization of different 
devices, including microfluidic chips, mass spectrometry, and others [203-205]. I am 
interested on miniaturization of capillary electrophoresis systems, which is commonly 
referred to as microfluidic chips [203, 206], or micro total analysis systems (µTAS), for 
further research. 
Since the hexyl acrylate based monolithic capillary columns were fabricated, the 
potential exists to introduce the monomer mixture into the small channel of the microchip 
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plate, polymerize the mixture, and shape it to the desired structure inside the microchip 
channel. 
At the moment, there are two ways of in situ polymerization for preparing a 
continuous monolithic bed, chemical initiation [207, 208] and photoinitiation [203, 209-
212]. The polymerization method presented in Chapter 2 utilized photoinitiation by a 360 
nm UV box. In addition, mass spectrometry detection was even coupled with monolithic 
CEC microchips for a protein digest analysis [210]. 
 
Figure 7.2 A polymer-based monolithic CEC microchip was fabricated by Daniel J. 
Throckmorton, Timothy J. Shepodd, and Anup K. Singh. The structure was photoinitiated 
using acrylate based monomer mixture. Adapted with permission from Ref. [203]. 
Copyright (2002) American Chemical Society. 
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Figure 7.3 Schematic diagram of the microchip CEC-MS configuration: (1) separation 
channel; (2) double-T injector; (3) ESI source; (4) eluent reservoir; (5) sample inlet 
reservoir; (6) sample waste reservoir; (7) eluent waste reservoir that houses the porous 
glass gate; (8) side channel for flushing the monolithic channel; (9) ESI emitter. Adapted 
with permission from Ref. [210]. Copyright (2003) WILEY-VCH. 
7.3 Capillary Zone Electrophoresis for Chiral Separation 
As detailed in Chapter 4 and 5, simultaneous enantioseparation of 12 cathinone 
analogs was successfully achieved by β-CD and HS-γ-CD. It is possible to use other 
chiral selectors as alternative ways to fulfill the goal of enantioseparation using CE with 
UV and MS detection. Several chiral selectors have been reported for chiral separations, 
including antibiotics [128, 132, 213, 214], crown ether [121, 124, 126, 215, 216], and 
other compounds [217, 218]. However, it should be noted that among various chiral 
selectors, CD and its derivatives are the most widely used chiral selectors by far because 
of their low UV absorption in 190 – 400 nm band and because of their widespread 
commercial availability. I would like to continue the research by choosing volatile chiral 
selectors, which are MS-friendly. 
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Figure 7.4 Chemical structure of 18C6H4. 
 
Figure 7.5 Chemical structure of penicillin G potassium salt (PenG) used as chiral 
selector in Ref. [116]. 
 
 
 
 
99 
 
 
 
 
 
 
"An education isn’t how much you have committed to memory, or even how much you 
know. It’s being able to differentiate between what you do know and what you don’t." 
Anatole France, French author, 1844–1924. 
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APPENDICES 
I. In situ synthesis of monolithic stationary phases for electrochromatographic separations 
1. Capillary pretreatment 
Cut a 100 μm I.D. transparent capillary to the required length, i.e. 80 cm. Rinse the 
capillary based on the following order. 
 Acetone – 5 min 
 NaOH – 60 min 
 6 mM acetic acid* containing 4 μL of trimethoxysilylpropyl acrylate (TMSA) – 
10 min 
 Static mode – 60 min 
 H2O – 30 min 
 N2 – 15 min (Use an empty vial at inlet) 
* 6 mM acetic acid: Add 34 μL glacial acetic acid to deionized water, total vol. 100 mL. 
2. Preparation of the polymerization mixture. 
Polymerization solution consists of a mixture of a monomer mixture (A) with 4mL of the 
porogenic solvent (B). 
A. consists of a mixture which contain hexyl acrylate (76%, 1369uL); 1,3-butanediol 
diacrylate (24%, 591uL) ; 2-acrylamido-2-methyl-1-propanesulfonicacid (0.5%, 14.5mg) 
and trimethoxysilylpropyl acrylate (2uL) 
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B. a mixture of Ethanol, Phosphate Buffer (pH6.8, 5mM), and Acetonitrile (v/v/v=1/1/3, 
i.e. 2 mL/2 mL/6 mL)  
Phosphate buffer: 0.0371 g of monosodium phosphate, monohydrate and 0.062 g of 
Disodium phosphate, heptahydrate in 100 mL deionized water. 
AIBN (0.5 % with respect to monomer, 9.4mg) is added to the polymerization solution as 
initiator. The polymerization solution is then sonicated to obtain a clear solution and to 
remove dissolve air. The solution MUST be clear. 
3. Monolithic column 
i. Filling 
The capillary is filled with the polymerization mixture by immersing the inlet of the 
capillary into a reservoir and by pushing the polymerization solution under gas pressure. 
After 30 min, its ends are sealed.  
ii. Polymerization 
The capillary is then placed into an UV oven 365nm during 1h at room temperature. Then 
2cm of both ends are cut and the capillary is put in the CE instrument. The monolith must 
be present in the entire capillary. 
iii. Washing (Post-treatment) 
Before any analysis, a voltage program ranging from 0 to 20kV in 120 min with a total 
duration of 300min is applied on the capillary with a mobile phase which consists of a 
mixture Acetonitrile/Phosphate Buffer pH6.8 (80/20). A pressure of 5 bar provided by 
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pressurized nitrogen is applied at both ends of the capillary during every experimental 
runs to minimize bubble formation. A detection window is created on the column as a 
result of exposure to the deuterium light of the detector. At the end of the conditioning 
the UV noise must be around 0.1mAU, and a stable current around 2-4uA (30kV applied) 
must be observed. 
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II. Instructional guidelines for the usage of the Agilent Chem Station in CE/CEC mode. 
1. Disconnect CE with TOF-MS. See diagram on the back of the MS for details. 
2. Turn on CE. The ON/OFF switch is on the lower left side of the front panal. 
3. Start the Agilent ChemStation (Instrument 1 Online) 
     a. Go to menu bar. Select Instrument. 
 Select system INIT 
     b. Wait for ready (Green light in the status bar of the software) 
     c. Click on Run method 
4. If you plan to not use the instruments for a few hours: 
 Turn off the CE lamp  
5. At the end of the day: 
     a. Turn off the CE lamp 
     b. Close ChemStation software 
     c. Turn off the CE 
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